GILD


Line plots across dimensions of each concept
Line plots across concepts
Tables

Table of contents



us-gaap:CommonStockValue

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesAuthorized

us-gaap:PreferredStockSharesAuthorized

us-gaap:CommonStockSharesOutstanding
us-gaap:StatementEquityComponents

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:EarningsPerShareBasic
us-gaap:BusinessAcquisition
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:EarningsPerShareDiluted
us-gaap:BusinessAcquisition
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:CostOfGoodsAndServicesSold

us-gaap:CostsAndExpenses

us-gaap:GrossProfit

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

us-gaap:IncomeTaxExpenseBenefit

us-gaap:InterestExpense

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:NonoperatingIncomeExpense

us-gaap:OperatingIncomeLoss

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
us-gaap:ProductOrService, us-gaap:StatementGeographical
us-gaap:StatementGeographical

us-gaap:Revenues
us-gaap:ProductOrService
us-gaap:ProductOrService, us-gaap:StatementGeographical
us-gaap:StatementGeographical

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:Assets

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:MarketableSecuritiesCurrent

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet
us-gaap:BalanceSheetLocation

us-gaap:PrepaidExpenseAndOtherAssetsCurrent
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:Land

us-gaap:MachineryAndEquipmentGross
us-gaap:StatementGeographical
us-gaap:NoncurrentAssets

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:ConstructionInProgressGross

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AmortizationOfIntangibleAssets

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

us-gaap:Goodwill
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OtherAssetsNoncurrent
us-gaap:BalanceSheetLocation
us-gaap:EquitySecuritiesFvNi
us-gaap:BalanceSheetLocation, us-gaap:FairValueByAssetClass
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:BalanceSheetLocation
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:AccountsPayableCurrent

us-gaap:AccruedIncomeTaxesCurrent

us-gaap:AccruedLiabilitiesCurrent

us-gaap:DebtCurrent

us-gaap:LiabilitiesCurrent

us-gaap:LongTermDebtCurrent

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:LongTermDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:LongtermDebtType

us-gaap:LongTermDebtNoncurrent

us-gaap:DeferredIncomeTaxLiabilitiesNet

us-gaap:MinorityInterest

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:OperatingLeaseLiability

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapital

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:MinorityInterest

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:DeferredIncomeTaxExpenseBenefit

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInInventories

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents

us-gaap:ShareBasedCompensation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:RepaymentsOfLongTermDebt
us-gaap:DebtInstrument, us-gaap:SubsequentEventType
us-gaap:StatementScenario, us-gaap:DebtInstrument

us-gaap:PaymentsOfDividends

us-gaap:Dividends
us-gaap:StatementEquityComponents

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:EffectiveIncomeTaxRateContinuingOperations
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:DeferredTaxLiabilities

us-gaap:DeferredTaxAssetsNet

us-gaap:UnrecognizedTaxBenefits

us-gaap:DeferredTaxAssetsValuationAllowance
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
gild:CashPaymentsMadeRelatedToEquityInvestments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
gild:CollaborationArrangementNetProductSalesThreshold
dei:LegalEntity, us-gaap:TypeOfArrangement
gild:CollaborationArrangementPercentOfGlobalDevelopmentAndCommercializationCosts
us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
gild:CollaborationArrangementPercentOfGlobalProductRevenues
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquitySecuritiesFVNISharesAcquired
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
gild:FiniteLivedIntangibleAssetsGrossReclassified
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
us-gaap:StatementScenario, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:SubsequentEventType
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:InvestmentOwnedBalanceAdditionalPayable
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:IssuanceDiscountPremium
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
gild:PaymentForAdjustmentsOfBudgetedDevelopmentCosts
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PaymentsForDirectTransactionalExpense
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
gild:PaymentsForResearchAndDevelopmentMilestones
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PaymentsToAcquireEquitySecuritiesFVNI

gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
gild:TotalUpfrontPaymentsMade
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement
gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements

us-gaap:AdjustmentForAmortization
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationAcquisitionRelatedCosts
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationConsiderationTransferred1
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory

us-gaap:CommonStockDividendsPerShareDeclared
us-gaap:MajorCustomers, us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType
us-gaap:ConcentrationRiskPercentage1

us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice

us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
us-gaap:ProductOrService
us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:VariableRate
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1

us-gaap:Depreciation

us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

us-gaap:DividendsCommonStockCash

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:EquitySecuritiesFvNiUnrealizedLoss
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:GoodwillAcquiredDuringPeriod

us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
us-gaap:LitigationCase, us-gaap:LitigationStatus
us-gaap:LossContingencyDamagesSoughtValue

us-gaap:MinorityInterestPeriodIncreaseDecrease
us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap:StatementEquityComponents
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax

us-gaap:OtherNoncashIncomeExpense

us-gaap:PaymentsForProceedsFromOtherInvestingActivities

us-gaap:PaymentsToAcquireAvailableForSaleSecurities

us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
us-gaap:BusinessAcquisition
us-gaap:PaymentsToAcquireBusinessesGross
us-gaap:BusinessAcquisition, us-gaap:StatementClassOfStock

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
us-gaap:PaymentsToAcquireEquityMethodInvestments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi

us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:PaymentsToAcquireOtherInvestments

us-gaap:ProceedsFromDebtNetOfIssuanceCosts

us-gaap:ProceedsFromIssuanceOfCommonStock
us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:SubsequentEventType
us-gaap:ProceedsFromLongTermLinesOfCredit

us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities

us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
us-gaap:StatementEquityComponents
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap:StatementScenario, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType
us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty

us-gaap:RepaymentsOfDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:RepaymentsOfUnsecuredDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:SubsequentEventType

us-gaap:ResearchAndDevelopmentInProcess
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation

us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents

us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
us-gaap:ShareRepurchaseProgram

us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
us-gaap:ShareRepurchaseProgram
us-gaap:StatementEquityComponents
us-gaap:StockRepurchasedDuringPeriodShares

us-gaap:StockRepurchasedDuringPeriodValue
us-gaap:StatementEquityComponents

us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions

gild:AccountsReceivableCashDiscountsAndOtherCurrent

gild:AccountsReceivableChargebacksCurrent

gild:AccruedGovernmentAndOtherRebates
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:AccruedResearchAndDevelopmentMilestonePayments

gild:Accruedgovernmentandotherrebates
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass
gild:AcquiredFiniteLivedIntangibleAssetsDiscountRate
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:AdjustmentsOfBudgetedDevelopmentCostsPaymentsDueNextTwelveMonths
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:AdjustmentsOfBudgetedDevelopmentCostsPaymentsDueYearTwo

gild:AllowanceforAccountsReceivableandChargebacks

gild:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost

gild:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
us-gaap:BusinessAcquisition, us-gaap:MeasurementInputType
gild:BusinessCombinationFutureRoyaltiesLiabilityMeasurementInput
us-gaap:BusinessAcquisition
gild:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFutureRoyaltiesLiability
us-gaap:BusinessAcquisition
gild:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNet

gild:DeferredTaxAssetsUpfrontAndMilestonePayments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquityMethodInvestmentOptionExerciseFee
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquityMethodInvestmentOptionFeeAndPotentialFutureMilestonePayments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquitySecuritiesFVNIAdditionalOptionFeeOnFourthSixthAndEighthAnniversaries
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquitySecuritiesFVNIAdditionalOptionFeeOnSecondAnniversary
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquitySecuritiesFVNIFutureMaximumMilestonePayments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:EquitySecuritiesFVNIShares

gild:FiniteLivedAndIndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss

gild:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour

gild:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLossCumulativeGainLoss
us-gaap:FiniteLivedIntangibleAssetsByMajorClass

gild:IndefiniteLivedIntangibleAssetsAcquiredDiscountRate
us-gaap:BusinessAcquisition, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:MeasurementInputType
gild:IntangibleAssetMeasurementInput
us-gaap:BusinessAcquisition, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:MeasurementInputType

gild:InventoryNetAndInventoryNoncurrent
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
gild:InvestmentOwnedBalanceAdditionalShares
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:LitigationCase
gild:LossContingencyEstimateOfPossibleLoss50EnhancementOfPastDamages
us-gaap:LitigationCase
gild:LossContingencyEstimateOfPossibleLossRoyalties
us-gaap:LitigationCase
gild:LossContingencyEstimateOfPossibleLossRoyaltiesAndPostJudgmentInterest
us-gaap:LitigationCase
gild:LossContingencyEstimateofPossibleLoss50EnhancementofPastDamages
us-gaap:LitigationCase
gild:LossContingencyEstimateofPossibleLossPastSales
us-gaap:LitigationCase
gild:LossContingencyEstimateofPossibleLossRoyaltiesandPrejudgmentInterest
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
gild:NumberOfAgreements
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PotentialClinicalRegulatoryAndCommercialMilestonePaymentsMaximum
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PotentialFutureMaximumMilestonePayments
us-gaap:BusinessAcquisition
gild:PotentialFutureMilestonePaymentsMaximum
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PotentialPaymentForAdjustmentsOfBudgetedDevelopmentCosts
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PotentialSalesBasedTieredRoyaltiesHighEndPercentage
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
gild:PotentialSalesBasedTieredRoyaltyLowEndPercentage
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
gild:ResearchAndDevelopmentFutureMaximumPayments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
gild:TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:AccountsReceivableGrossCurrent

us-gaap:AccruedIncomeTaxesNoncurrent

us-gaap:AllowanceForDoubtfulAccountsReceivable

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent

us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByAssetClass
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
us-gaap:FinancialInstrument

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
us-gaap:FinancialInstrument

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:BuildingsAndImprovementsGross
us-gaap:BusinessAcquisition, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BusinessCombinationContingentConsiderationLiability
us-gaap:BusinessAcquisition, us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency
us-gaap:Range, us-gaap:BusinessAcquisition
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
us-gaap:BusinessAcquisition, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet

us-gaap:CapitalizedComputerSoftwareNet
us-gaap:AwardType
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

us-gaap:ContractWithCustomerAssetNet

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerRefundLiabilityCurrent

us-gaap:DebtInstrumentCarryingAmount
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
us-gaap:FinancialInstrument
us-gaap:FinancialInstrument
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
us-gaap:FinancialInstrument
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
us-gaap:BalanceSheetLocation
us-gaap:FinancialInstrument
us-gaap:FinancialInstrument
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
us-gaap:FinancialInstrument
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions

us-gaap:DeferredIncomeTaxLiabilities

us-gaap:DeferredTaxAssetsEquityMethodInvestments

us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards

us-gaap:DeferredTaxAssetsOther

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies

us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

us-gaap:DeferredTaxLiabilitiesOther

us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment

us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
us-gaap:BalanceSheetLocation, us-gaap:HedgingDesignation
us-gaap:HedgingDesignation

us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection

us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction

us-gaap:DerivativeAssets

us-gaap:DerivativeFairValueOfDerivativeAsset

us-gaap:DerivativeFairValueOfDerivativeLiability

us-gaap:DerivativeLiabilities

us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
us-gaap:BalanceSheetLocation, us-gaap:HedgingDesignation
us-gaap:HedgingDesignation

us-gaap:DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection

us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction

us-gaap:DerivativeNotionalAmount

us-gaap:EmployeeRelatedLiabilitiesCurrent
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:EquityMethodInvestmentOwnershipPercentage
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:EquityMethodInvestments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement
us-gaap:EquityMethodInvestmentsFairValueDisclosure

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

us-gaap:FiniteLivedIntangibleAssetsGross
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency

us-gaap:ForeignCurrencyExchangeRateTranslation1
us-gaap:BusinessAcquisition
us-gaap:GoodwillGross

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:InterestReceivableCurrent

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryNoncurrent

us-gaap:InventoryRawMaterialsNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType
us-gaap:InvestmentOwnedBalanceShares
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:LiabilitiesFairValueDisclosure
us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency
us-gaap:CreditFacility, us-gaap:DebtInstrument
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:LongTermDebtFairValue

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
us-gaap:LitigationCase, us-gaap:Range
us-gaap:LossContingencyEstimateOfPossibleLoss

us-gaap:MarketableSecuritiesNoncurrent
us-gaap:Ownership, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement
us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
us-gaap:Ownership, us-gaap:TypeOfArrangement

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
us-gaap:IncomeTaxAuthority
us-gaap:OperatingLossCarryforwards
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:OtherLiabilitiesFairValueDisclosure
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency

us-gaap:PropertyPlantAndEquipmentOther
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap:PlanName, us-gaap:StatementClassOfStock
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
us-gaap:PlanName, us-gaap:StatementClassOfStock
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
us-gaap:IncomeTaxAuthority
us-gaap:TaxCreditCarryforwardAmount

us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
us-gaap:OtherCommitments
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary
us-gaap:OtherCommitments
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
us-gaap:OtherCommitments
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary
us-gaap:OtherCommitments
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary
us-gaap:OtherCommitments
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary

Plots across concepts


IncomeStatement
Other Comprehensive Income Loss Net Of Tax
Expenses
Interest Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Derivative Assets
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Derivative Liabilities
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Minority Interest
Stockholders Equity
Common Stock Value
Per Share
Common Stock Dividends Per Share Declared
CashFlow
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Prepaid Deferred Expense And Other Assets
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Common Stock Shares Issued
DividendsAndRepurchase
Payments For Repurchase Of Common Stock
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Four
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Work In Process Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Tables

  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:CommonStockValue ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂█▂█▅▅▅▅▁▁▁▁▁▁▁▁▁▁▁▁1.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.02.01.02.01.5141.5261.5381.5340.7630.7650.760.760.7580.7560.7580.7530.7570.7770.7910.802NANANA0.9NANANA
us-gaap:CommonStockSharesIssued 1254.0NA1254.0NA1254.01254.01266.01266.01267.01274.01282.01294.01296.01300.01308.01307.01306.01307.01310.01322.01331.01348.01422.01449.01473.01477.01499.01513.5931526.0431537.6421534.4141534.0281528.891524.3831519.163757.933756.153758.19753.106756.094776.4050.79147801.998NANANA899.753NANANA
us-gaap:CommonStockSharesAuthorized 5600.0NA5600.0NA5600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.05600.02800.02800.02800.02800.02800.02800.02.82800.02.82800.0NANANA2800.0NANANA
us-gaap:PreferredStockSharesAuthorized 5.0NA5.0NA5.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.05.00.0055.0NANANA5.0NANANA
us-gaap:CommonStockSharesOutstanding 1254.0NA1254.0NA1254.01254.01266.01266.01267.01274.01282.01294.01296.01300.01308.01307.01306.01307.01310.01322.01331.01348.01422.01449.01473.01477.01499.01513.5931526.0431537.6421534.4141534.0281528.891524.3831519.163757.933756.153758.19753.106756.094776.4050.79147801.998NANANA899.753NANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding ▁█1260.01262.0NA1261.01255.01270.0NA1267.01277.01283.0NA1307.01308.01320.0NA1319.01317.01320.0NA1339.01355.01412.0NA1503.01540.01569.0NA1636.531664.4151679.871NA1691.8981694.5771665.06NA792.304780.506777.388NA781.312800.8811.857NA847.228898.753928.368NANANANA
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic ▁█1255.01256.0NA1255.01255.01262.0NA1267.01270.01276.0NA1296.01298.01307.0NA1306.01307.01308.0NA1322.01335.01383.0NA1463.01472.01488.0NA1513.8991532.7231536.525NA1532.1051526.9451521.372NA757.385756.951756.286NA767.033784.807796.115NA833.006881.802901.606NANANANA
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount █▁19.015.0NA13.038.014.0NA40.017.016.0NA12.021.012.0NA9.013.09.0NA4.0NA4.0NA1.01.01.0NA1.11.10.7NA0.11.01.3NA2.19.210.9NA21.021.622.1NA27.123.418.0NANANANA
us-gaap:EarningsPerShareBasic ▆▆▆▅▁▆▇▃▆▆▄▆▆▆▁▇▇▇▇▇▇▇████▇▆▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1.211.381.240.29-2.661.232.13-0.921.481.550.01.621.41.18-2.962.082.352.072.362.522.622.583.263.143.052.912.321.82.391.450.520.510.510.470.50.890.940.580.880.970.950.820.780.850.810.950.890.750.630.65
us-gaap:EarningsPerShareDiluted ▆▆▆▅▁▆▇▃▆▆▄▆▆▆▁▇▇▇▇▇▇▇████▇▆▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1.211.371.230.29-2.661.222.12-0.921.471.540.01.61.391.17-2.962.062.332.052.342.492.582.533.183.062.922.762.181.672.21.330.470.470.460.430.470.850.910.570.870.950.930.80.760.830.790.920.870.720.610.63
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
 TTM Greenblatt ROC _ _▅▆▆▅▁▅▄▂▅▅▄▆▅▅▅▇▇▆▇▇▇▇████▇▆▇▆▄▄▄▄▄▄▄▄▄▄▄▄▄2246.02890.02651.02001.0-2983.02402.01093.0-1473.02430.02237.01144.02623.02280.02153.02291.03812.04254.03767.04045.04399.04538.04651.05621.05585.05616.05371.04330.3723479.2234412.7553042.651197.0411147.8611153.8381025.2591106.9831043.9141059.092800.186867.4761003.6781016.718901.969829.381NANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:ComprehensiveIncomeNetOfTax ▅▆▅▄▂▅▆▃▆▆▄▆▆▅▁▇▇▆▇▇▇▇████▇▇▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1523.01827.01468.0313.0-3315.01512.02664.0-1150.01852.02025.047.02131.01989.01496.0-3949.02847.02933.02684.03494.03268.03615.03314.04604.04520.04200.04571.03613.3152946.6963709.9022256.087709.035716.165782.17788.607688.677579.377796.86417.347750.08855.276710.361515.209661.299520.024815.278941.325NANANANA
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest ▄▃▃▃▃▃▃▄▄▃▄▅▅▄█▃▄▄▃▄▄▄▅▃▅▄▁▃▄▄▄▄▄▄-5.0-7.0-7.0-7.0-7.0-13.0-7.0-3.0-5.0-7.00.02.02.01.029.0-6.0-4.0-3.0-9.0-5.00.01.02.0-8.05.0-1.0-25.058-7.011-5.108-4.823-4.669-3.39-4.987-4.476NANANA-4.425-3.386-3.586-3.768-3.838NA-2.713-2.934-2.807NANANANA
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest ▅▆▅▄▁▅▆▃▆▆▄▆▆▅▁▇▇▆▇▇▇▇████▇▇▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1518.01820.01461.0306.0-3322.01499.02657.0-1153.01847.02018.047.02133.01991.01497.0-3920.02841.02929.02681.03485.03263.03615.03315.04606.04512.04205.04570.03588.2572939.6853704.7942251.264704.366712.775777.183784.131685.095574.907802.35417.347724.31858.862714.129519.047641.337522.737818.212944.132NANANANA
us-gaap:CostOfGoodsAndServicesSold ▅▅▅▃▂▁█▂▁▁▇▂▃▁▄▂▃1390.01361.01398.01141.01064.0969.01683.01035.01000.0957.01570.01086.01196.01001.01256.01032.01126.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:CostsAndExpenses ▄▄▅▅█▃▅▇▃▃▅▃▃▃▄▃▃▃▃▃▃▃▃▃▃▂▃▃▂▂▂▂▂▂▂▁▁▂▁▁▁▁▁▁▁▁3971.03533.04770.04576.08126.03146.04786.07077.03255.03044.04651.02973.03368.02935.03658.02700.02887.02738.03275.03101.03238.03143.02885.02710.02628.02223.02983.8972562.6092122.1881956.3061922.7851634.9721613.5561506.3761481.3021382.6831346.0941482.2631332.9021117.9821120.5351024.1251169.306958.583934.597924.712NANANANA
us-gaap:GrossProfit NANA5930.05352.04003.04498.04113.04481.04607.04243.04111.04369.04344.04000.04581.05370.05920.05420.06141.06276.06787.06488.07347.07147.07128.06523.06159.04981.05488.04058.02185.6672027.7841972.6221759.121834.9931760.7091703.8951627.4111548.8871533.871505.7251389.4671433.9011387.9751350.5361347.6331330.9991239.2551185.3331118.166
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments ▅▅▅▄▁▅▅▂▅▅▄▆▅▅▅▆▇▆▇▇▇▇████▇▆▇▆▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄1817.02264.01814.0825.0-2973.02003.01901.0-1501.02410.02350.01016.02664.02086.02033.02126.03671.04115.03617.03920.04276.04399.04502.05437.05472.05511.05239.04229.6053370.824307.1062948.4691112.7831079.6891075.599940.1481022.463951.087969.599668.831818.843974.987982.589874.585799.523961.046993.1481159.831NANANANA
us-gaap:IncomeTaxExpenseBenefit ▂▂▂▂▂▂▁▁▂▂▃▂▂▂█▃▃▃▃▃▃▃▃▃▃▃▃▂▂▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂300.0542.0270.0472.0373.0465.0-788.0-333.0535.0382.01013.0565.0267.0494.05962.0959.01046.0918.0821.0951.0902.0935.0752.0880.01014.0907.0767.94646.557656.621725.882326.041294.473307.981222.438263.504280.052263.525231.3157.084237.449240.13227.282173.158258.883284.021307.737NANANANA
us-gaap:InterestExpense ▇▇▇▆▇▇▇▇▇▇▇▇▇███▇▇▇▇▆▆▆▅▄▄▄▃▃▂▂▂▃▃▃▃▃▃▂▂▂▂▂▁▁▁256.0257.0267.0236.0240.0241.0243.0250.0248.0254.0257.0264.0266.0290.0297.0291.0269.0261.0265.0242.0227.0230.0230.0165.0140.0153.0130.361103.366102.00476.26973.1573.94978.00881.78785.90689.32288.41897.2774.99843.09746.10741.21640.62233.6217.76416.955NANANANA
us-gaap:NetIncomeLoss ▅▆▅▄▁▅▆▃▆▆▄▆▆▅▁▆▇▆▇▇▇▇████▇▆▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1522.01729.01551.0360.0-3339.01551.02696.0-1165.01880.01975.03.02097.01817.01538.0-3865.02718.03073.02702.03108.03330.03497.03566.04683.04600.04492.04333.03487.02731.2743655.5932227.41791.411788.606772.605722.186762.541675.505706.074437.531665.145741.124746.227651.141629.419704.876712.061854.901802.212673.033571.398589.112
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest ▄▃▃▃▃▃▃▄▄▃▄▅▅▄█▃▄▄▃▄▄▄▅▃▅▄▁▃▄▄▄▄▄▄▄▄▄▅█▄▄▄▄▄▄▄-5.0-7.0-7.0-7.0-7.0-13.0-7.0-3.0-5.0-7.00.02.02.01.029.0-6.0-4.0-3.0-9.0-5.00.01.02.0-8.05.0-1.0-25.058-7.011-5.108-4.823-4.669-3.39-4.987-4.476-3.582-4.47-5.494.42525.77-3.586-3.768-3.838-3.054-2.713-2.934-2.807NANANANA
us-gaap:NonoperatingIncomeExpense ▄▃▂▁▅▄█▅▅▆▅▅▅▅▅▅▅▅▅▅▅▅▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄-173.0-369.0-570.0-940.0250.0-158.01051.0222.0228.0367.0129.0305.072.0170.0132.0150.0130.0111.0140.0119.088.081.046.052.035.021.029.594-5.037-3.645-17.912-11.1085.777-0.231-3.3241.386-3.505-1.075-34.08526.36514.40611.97813.83210.76415.59318.28515.645NANANANA
us-gaap:OperatingIncomeLoss ▅▆▆▅▁▅▄▂▅▅▄▆▅▅▅▇▇▆▇▇▇▇████▇▆▇▆▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄2246.02890.02651.02001.0-2983.02402.01093.0-1473.02430.02237.01144.02623.02280.02153.02291.03812.04254.03767.04045.04399.04538.04651.05621.05585.05616.05371.04330.3723479.2234412.7553042.651197.0411147.8611153.8381025.2591106.9831043.9141059.092800.186867.4761003.6781016.718901.969829.381979.073992.6271161.141NANANANA
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax ▄▆▂▂▂▅▂▅▃▄▅▄█▃▄▂▁7.090.0-69.0-57.0-52.034.0-57.038.0-34.0-1.047.02.0163.0-13.06.0-51.0-102.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax ▃▃▃▃▃▂▃▂▃▃▂▃▂▃▃▃▄▁█▂▃▃▃▃▃▃▃▃▃▃▂▃▃▃▃▃▃▃▃▃▃-5.010.010.023.04.0-39.025.0-27.0-13.021.0-21.01.0-25.07.04.0-4.029.0-76.0216.0-50.09.02.013.03.03.0-10.0-5.938-10.0311.1865.783-49.5952.38111.73-8.9563.735.09-2.6424.897-4.142-3.958-4.358NANANANANANANANANA
us-gaap:OtherComprehensiveIncomeLossNetOfTax ▄▅▃▄▄▄▄▄▄▅▄▄▆▄▃▅▃▄█▃▅▁▃▃▁▆▅▆▅▄▃▃▄▅▃▃▅▄▅▅1.098.0-83.0-47.024.0-39.0-32.015.0-28.050.044.034.0172.0-42.0-84.0129.0-140.0-18.0386.0-62.0118.0-252.0-79.0-80.0-292.0238.0126.592215.42254.30928.677-82.376-72.4419.56566.421-73.864-96.12890.786-24.60973.743117.738NANANANANANANANANANA
us-gaap:ProfitLoss ▅▆▅▄▁▅▆▃▆▆▄▆▆▅▁▆▇▆▇▇▇▇████▇▆▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1517.01722.01544.0353.0-3346.01538.02689.0-1168.01875.01968.03.02099.01819.01539.0-3836.02712.03069.02699.03099.03325.03497.03567.04685.04592.04497.04332.03462.02724.2633650.4852222.587786.742785.216767.618717.71758.959671.035711.564441.956661.759737.538742.459647.303626.365702.163709.127852.094799.393670.478569.145586.576
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost ▃▂█▃▅▁▂▁▁1134.01055.01578.01158.01299.01004.01099.01030.0995.0NANANANANANANANANANANANANANANANANANANANANANANANANA439.659465.831396.244458.211402.236290.066282.403254.446392.76230.44231.066218.664NANANANA
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▆▆▇▆▅▅▅▅▅▅▅▅▅▅▅▆▇▆▇▇▇▇███▇▇▆▆▄▃▂▂▂▂▂▂▂▂▂▂▁▁▁▁▂▂▁▁▁6217.06423.07421.06577.05143.05548.05879.05604.05685.05281.05795.05596.05648.05088.05949.06512.07141.06505.07320.07500.07776.07794.08506.08295.08244.07594.07314.06041.8326534.9434998.9563119.8262782.8332767.3942531.6352588.2852426.5972405.1862282.4492200.3782121.662137.2531926.0941998.6871937.6561927.2242085.8532032.3791801.3891647.1551530.46
us-gaap:Revenues ▆▆▇▆▅▅▅▅▅▅▅▅▅▅▅▆▇▆▇▇▇▇███▇▇▆▆▄▃▂▂▂▂▂▂▂▂▂▂▁▁▁▁▂▂▁▁▁6217.06423.07421.06577.05143.05548.05879.05604.05685.05281.05795.05596.05648.05088.05949.06512.07141.06505.07320.07500.07776.07794.08506.08295.08244.07594.07314.06041.8326534.9434998.9563119.8262782.8332767.3942531.6352588.2852426.5972405.1862282.4492200.3782121.662137.2531926.0941998.6871937.6561927.2242085.8532032.3791801.3891647.1551530.46
us-gaap:SellingGeneralAndAdministrativeExpense ▆▅█▅▆▅▆▅▅▅▅▄▄▅▆▄▄▄▅▄▄▃▅▄▄▃▄▄▃▂▂▂▂▂▂▁▁▂▁▁▁▁▁▁▁▁1351.01055.01730.01106.01239.01076.01204.01052.01095.01030.01131.0948.0980.0997.01252.0879.0897.0850.0992.0831.0890.0685.01066.0903.0812.0645.0876.485944.837613.555548.123513.284406.86404.991374.296365.825319.583332.505443.121346.219295.927304.269295.568280.209250.559248.006265.618NANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:Assets ███▇▆▇▇▇▇▇▇▇▇▇█▇▇▆▆▆▆▅▆▆▄▄▄▃▃▃▂▂▂▂▂▂▂▂▂▁▁▁▁67984.067492.068407.060878.055934.059741.061627.059146.063210.062837.063675.064305.065355.065381.070283.064662.060263.057701.056977.056609.049980.047765.051839.050637.039167.038321.034664.028844.39331206.16428077.69222496.78522468.42822624.37422211.66821239.83820963.82920501.9519950.38617303.13412639.89812694.1412987.35411592.63NANANA9698.559NANANA
us-gaap:LiabilitiesAndStockholdersEquity ███▇▆▇▇▇▇▇▇▇▇▇█▇▇▆▆▆▆▅▆▆▄▄▄▃▃▃▂▂▂▂▂▂▂▂▂▁▁▁▁67984.067492.068407.060878.055934.059741.061627.059146.063210.062837.063675.064305.065355.065381.070283.064662.060263.057701.056977.056609.049980.047765.051839.050637.039167.038321.034664.028844.39331206.16428077.69222496.78522468.42822624.37422211.66821239.83820963.82920501.9519950.38617303.13412639.89812694.1412987.35411592.63NANANA9698.559NANANA
us-gaap:StockholdersEquity ▆▆▆▅▅▇▇▆▇▇▇▇▇▆▆█▇▆▆▅▅▄▆▅▅▅▅▄▅▄▃▃▃▃▂▂▂▂▁▁▁▁▁19703.018952.018202.017445.018027.022067.022525.020604.022616.021951.021387.022861.021672.020591.020442.024845.022677.020441.018887.016868.015536.013398.018534.017414.016287.017180.015426.013566.22316090.62913387.32211369.06710883.6111092.010152.2319309.7398603.6428002.127313.6126738.8566116.7646046.8455946.2535863.729NANANA6367.065NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:AssetsCurrent ▃▃▃▇▅▆▇▆████▇▇▇█▆▅▄▅▄▄▅▆▄▄▄▃▃▃▁▁▁▁▁▁▁▁▃▁▁▁▁13925.013278.015996.030926.024643.026950.030296.028361.033727.034024.035836.034918.032728.030258.031823.035317.028592.021424.020445.021425.018353.019267.024763.025910.018093.020062.017714.012562.03115499.33912970.6297273.7536968.0617072.5296663.0976156.3475880.3795844.1025826.53213918.7856147.2676219.0456851.1325708.082NANANA4812.558NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue NANA5997.0NANANA11631.0NA11240.016927.017940.014569.013234.07643.07588.011508.08712.010285.08229.09809.06485.06315.012851.013965.07417.010635.010027.06209.068730.5226404.1532112.8062010.7362202.1761863.9721803.6941550.711625.51451.9429883.777909.359905.7791835.978907.8791022.9931482.639936.881272.958NANANA
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents ▁▁▂▅▂▄▅▄▅▇█▆4893.04065.05997.012886.06746.010051.011631.09474.011240.016927.017940.014569.0NANA7588.0NANANA8229.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:MarketableSecuritiesCurrent ▂▂▂▅▆▅▆▆▇▅▆▆▆▇██▆▂▂▂▂▂▂▂▁▁▁▁▁▁▁1632.01601.01411.011089.012168.010734.012721.013382.015943.010977.012149.013897.012683.016355.017922.016879.012384.03830.03666.02457.02267.02004.01756.01749.01194.0659.0101.0107.26668.54664.87718.756NANA78.80458.556144.77582.0440.016.4911347.7761364.5391175.3211190.789NANANA384.017NANANA
us-gaap:AccountsReceivableNetCurrent ▅▅▆▅▃▅▄▄▄▄▄▄▄▄▄▅▅▅▅▆▇███▇▆▆▃▄▃▂▂▁▁▁▁▁▂▂▁▁▁▁4149.03925.04892.03913.03194.03907.03582.03315.03396.03283.03327.03465.03541.03775.03851.04122.04478.04034.04514.05075.05752.06163.05854.06105.05331.04835.04635.02850.3673436.7113236.1952100.2861971.9261895.9131945.1891751.3881766.0911702.8182163.6591951.1671867.0921938.6451801.2121621.966NANANA1389.534NANANA
us-gaap:InventoryNet ▆▆▆▂▂▂▂▁▁▂▁▁▁▁▁▃▄▅▅▇▇▇▇▇▇▇▄▇███▇▇▆▆▅▅▄▄▄▄▄▃1772.01779.01683.01008.01052.0986.0922.0882.0884.0898.0814.0816.0859.0885.0801.01144.01408.01474.01587.01900.01862.01880.01955.01988.02039.01908.01386.01909.5842068.7532140.2282055.7881946.0481935.1471799.6181744.9821617.3691603.4011418.0331389.9831337.7511321.6151304.4571203.809NANANA1051.771NANANA
us-gaap:PrepaidExpenseAndOtherAssetsCurrent ▃▅▆▆▃▂▃▂▇▅▄▇█▃▄▄▄▅▃▃▁▆▃▁1479.01908.02013.02030.01483.01272.01440.01308.02264.01939.01606.02171.02411.01600.01661.01664.01610.01801.01592.01422.01152.02075.01519.01209.0NANA1057.0NANANANANANANA186.666NANANA222.768NANANANANANANANANANANA
us-gaap:Land NANA404.0NANANA404.0NANANA404.0NANANA396.0NANANA394.0NANANA393.0NANANA254.0NANANA195.91NANANA195.813NANANA149.376NANANA137.812NANANANANANANA
us-gaap:MachineryAndEquipmentGross NANA904.0NANANA805.0NANANA697.0NANANA533.0NANANA469.0NANANA377.0NANANA327.0NANANA250.167NANANA205.097NANANA199.693NANANA168.711NANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
 us-gaap:NoncurrentAssets us-gaap:StatementGeographical country:USNANA3800.0NANANA3500.0NANANA3200.0NANANA2600.0NANANA2200.0NANANA1800.0NANANA1300.0NANANA883.0NANANANANANANANANANANANANANANANANANANA
 us-gaap:NoncurrentAssets us-gaap:StatementGeographical us-gaap:NonUsNANA897.0NANANA791.0NANANA620.0NANANA520.0NANANA430.0NANANA334.0NANANA275.0NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PropertyPlantAndEquipmentGross NANA6635.0NANANA5924.0NANANA5197.0NANANA4289.0NANANA3683.0NANANA2646.0NANANA2040.0NANANA1472.238NANANA1327.746NANANA983.293NANANA879.79NANANANANANANA
us-gaap:ConstructionInProgressGross NANA856.0NANANA723.0NANANA1194.0NANANA690.0NANANA641.0NANANA554.0NANANA411.0NANANA129.4NANANA216.434NANANA60.746NANANA82.334NANANANANANANA
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment NANA1668.0NANANA1422.0NANANA1191.0NANANA994.0NANANA818.0NANANA763.0NANANA620.0NANANA501.967NANANA423.3NANANA358.263NANANANANANANANANANANA
us-gaap:AmortizationOfIntangibleAssets █▁440.0395.0NA281.0282.0281.0NA281.0288.0299.0NA301.0300.0301.0NANANANANANANANANANANANANANANANANANA21.521.515.815.815.815.817.417.417.4NANANANANANANANANA
us-gaap:PropertyPlantAndEquipmentNet ████▇▇▇▇▇▇▆▆▆▅▅▅▅▅▅▄▄▄▄▃▃▃▃▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁4996.04990.04967.04810.04653.04564.04502.04377.04249.04116.04006.03791.03659.03415.03295.03100.03012.02922.02865.02714.02599.02431.02276.02143.01899.01765.01674.01509.7961380.7761303.0291166.1811133.0321135.9931125.7941100.259856.184811.799782.867774.406761.19721.884703.794701.235NANANA699.97NANANA
us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures █▃▁93.069.058.0NANANA24.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:Goodwill ███▄▄▄▄▄▄▄▄▄▄▄▄▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁▁8334.08334.08108.04117.04117.04117.04117.04117.04117.04117.04117.04117.04124.04159.04159.01172.01172.01172.01172.01172.01172.01172.01172.01172.01172.01172.01172.01171.5611171.5611171.5611169.0231188.1571188.1571188.1571060.9191078.9191078.9191078.9191004.1021004.1021004.102754.456532.669NANANA462.558NANANA
 us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass us-gaap:InProcessResearchAndDevelopment███▁▁16120.017170.016890.01130.01247.0NA1247.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill ███▃▄▄▄▄▄▄▄▄▄▄▄▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▁34341.034781.033126.012939.013225.013502.013786.014864.015152.015438.015738.016314.016496.016803.017100.08342.08551.08761.08971.09386.09713.09923.010247.010454.010660.010867.011073.011306.54711508.31911707.8311900.10612034.45712056.00212077.54811736.39311735.35411751.19111767.0271062.864NANANANANANANANANANANA
us-gaap:FiniteLivedIntangibleAssetsNet ██▇▅▆▆▆▆▆▆▆▆▆▆▆▄▄▄▄▄▄▅▅▅▅▅▅▅▅▅▅▁▁▁▁▁▁18221.017611.016236.011809.011983.012262.012544.012824.013109.013396.013694.013447.013746.014053.014350.08342.08551.08761.08971.09185.09395.09605.09815.010022.010228.010435.010641.010874.15710926.72911126.2411325.751685.557707.102728.648750.193749.154764.991NA796.664NANANA863.393NANANA923.319NANANA
us-gaap:OperatingLeaseRightOfUseAsset NANA646.0NANANA668.0660.0504.0455.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAssetsNoncurrent ▆▆▆▇███▆▄▄▃▄▃▃▃▃▃▃▃▂▂▂▂▂▂▁▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁5552.05530.05708.06012.07020.07079.07438.05232.02914.02921.02555.02787.02609.02642.02722.02611.02319.02312.02214.01647.01481.01294.01056.0858.0682.0583.0731.0267.486212.8204.461195.163139.47143.941149.948159.187170.629171.283169.308160.674131.649119.368125.595181.149NANANA85.635NANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation us-gaap:CashAndCashEquivalentsNANA4361.0NANANA7069.0NA3007.03778.05305.05138.07060.0NA4714.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation us-gaap:OtherNoncurrentAssetsNANA1756.0NANANA174.0NA166.0162.0142.0135.0128.0NA114.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation us-gaap:PrepaidExpensesAndOtherCurrentAssetsNANA853.0NANANA319.0NA1178.01105.0863.0829.0666.0NA637.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation,us-gaap:FairValueByAssetClass us-gaap:CashAndCashEquivalents,gild:OtherEquitySecurities▂▁▃█▃▅▅▂3383.02216.04361.011430.04419.07763.07069.03599.0NANA5305.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation,us-gaap:FairValueByAssetClass us-gaap:OtherNoncurrentAssets,gild:OtherEquitySecurities▄▄▄▅███▁1792.01708.01756.02194.03522.03472.03651.0163.0NANA142.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation,us-gaap:FairValueByAssetClass us-gaap:PrepaidExpensesAndOtherCurrentAssets,gild:OtherEquitySecurities▂▆▇█▃▁▂▁319.0797.0853.0986.0451.0239.0319.0292.0NANA241.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency gild:DeferredCompensationPlan,us-gaap:FairValueInputsLevel1,us-gaap:FairValueMeasurementsRecurring█▇▆▅▄▃▄▃▃▂▁▂▁248.0235.0218.0200.0183.0156.0171.0159.0156.0150.0124.0139.0131.0NA116.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency gild:EquityinvestmentinGalapagos,us-gaap:FairValueInputsLevel1,us-gaap:FairValueMeasurementsRecurring▁▁▂▅▇██▄1164.01302.01648.02361.03283.03316.03477.02082.0NANA622.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency us-gaap:EquitySecurities,us-gaap:FairValueInputsLevel1,us-gaap:FairValueMeasurementsRecurring▄▆▅▄▃▁▂▁█▇▆▅▄699.0968.0743.0619.0507.0239.0322.0287.01172.01099.0881.0825.0663.0NA635.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency us-gaap:MoneyMarketFunds,us-gaap:FairValueInputsLevel1,us-gaap:FairValueMeasurementsRecurring▂▁▃█▃▅▅▂▂▂▃▃▅3383.02216.04361.011430.04419.07763.07069.03599.03007.03778.05305.05138.07060.0NA4714.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByMeasurementBasis,us-gaap:FairValueByMeasurementFrequency gild:DeferredCompensationPlan,us-gaap:EstimateOfFairValueFairValueDisclosure,us-gaap:FairValueMeasurementsRecurring█▇▆▅▄▃▄▃▃▂▁▂▁248.0235.0218.0200.0183.0156.0171.0159.0156.0150.0124.0139.0131.0NA116.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByMeasurementBasis,us-gaap:FairValueByMeasurementFrequency gild:EquityinvestmentinGalapagos,us-gaap:EstimateOfFairValueFairValueDisclosure,us-gaap:FairValueMeasurementsRecurring▁▁▂▅▇██▄1164.01302.01648.02361.03283.03316.03477.02082.0NANA622.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByMeasurementBasis,us-gaap:FairValueByMeasurementFrequency us-gaap:EquitySecurities,us-gaap:EstimateOfFairValueFairValueDisclosure,us-gaap:FairValueMeasurementsRecurring▄▆▅▄▃▁▂▁█▇▆▅▄699.0968.0743.0619.0507.0239.0322.0296.01188.01117.0881.0825.0663.0NA635.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass,us-gaap:FairValueByMeasurementBasis,us-gaap:FairValueByMeasurementFrequency us-gaap:MoneyMarketFunds,us-gaap:EstimateOfFairValueFairValueDisclosure,us-gaap:FairValueMeasurementsRecurring▂▁▃█▃▅▅▂▂▂▃▃▅3383.02216.04361.011430.04419.07763.07069.03599.03007.03778.05305.05138.07060.0NA4714.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName gild:GalapagosNV▁▃█1164.01302.01648.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName,us-gaap:BalanceSheetLocation gild:GalapagosNV,us-gaap:OtherNoncurrentAssets▅▁█1164.01026.01297.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName,us-gaap:BalanceSheetLocation gild:GalapagosNV,us-gaap:PrepaidExpensesAndOtherCurrentAssetsNA276.0351.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName,us-gaap:TypeOfArrangement gild:ArcusBiosciencesInc,gild:ArcusCollaborationAgreementAndStockPurchaseAgreementsNANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName,us-gaap:TypeOfArrangement gild:ArcusBiosciencesInc,gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreementNANANA135.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:AccountsPayableCurrent ▂▁▃▁▁▁▂▂▂▁▃▁▂▂▃▂▃▄▆▅▅▄▅▆█▄▄▅▅▆▆▇▇▇▆▆▇▆▆▅▅▄▃608.0570.0844.0527.0532.0590.0713.0632.0617.0577.0790.0580.0623.0711.0814.0696.0819.0944.01206.01052.01122.0945.01178.01239.01571.01011.0955.01182.9171162.3071234.5071255.9141350.4021390.6411356.3721327.3391319.671367.3531339.2571206.0521063.7231102.319981.631803.025NANANA810.544NANANA
us-gaap:AccruedIncomeTaxesCurrent ▃▁▅██▅▂439.0215.0598.0943.0911.0645.0287.0NANANA190.017.017.066.0713.0NANANA186.0390.0NA51.065.0159.0356.098.0105.043.78197.302152.95310.85510.65137.97419.2413.40317.08711.84714.49140.58333.6725.4382.4571.862NANANA167.623NANANA
us-gaap:AccruedLiabilitiesCurrent ▇▅█▇▆▃▄▃▂▁▄▁▂▁▅▂▃▂▃▅▃▃▄▂4055.03507.04336.04141.03696.02833.03074.02785.02760.02348.03139.02333.02607.02414.03370.02482.02991.02626.02790.03478.02830.02925.03172.02721.0NANA1873.0NANANANANANANANANA624.337593.063502.557495.312618.223566.573437.893NANANA384.015NANANA
us-gaap:DebtCurrent ▅▅▇▁█▃▆▆▃▆▇▇█▆▇▂2261.02259.02757.01498.02999.01999.02499.02498.01999.02498.02748.02747.02998.02497.02747.01747.0NANA0.0700.0700.01745.0983.0331.0352.0442.0483.01477.0821572.0791871.8112697.0441457.3791488.225942.8111169.491730.8951972.8161351.5731.5721.5877.345653.093646.345NANANA5.587NANANA
us-gaap:LiabilitiesCurrent ▇▇█▆▇▆▇▆▆▆▇▇▇▇█▆▆▆▆█▇▇▇▆▆▅▄▄▄▄▄▃▃▃▃▃▃▂▁▁▁▁▁10214.09705.011397.09509.010564.08879.09759.09567.08961.09397.010605.010116.010912.010670.011635.09597.08492.08282.09219.011073.010444.010910.09891.09360.08925.07428.05761.06054.9526227.9975914.7766325.4214895.1244937.1384290.2154270.024802.1484986.6744187.9042514.792224.4312310.8412768.7652464.95NANANA1871.631NANANA
us-gaap:LongTermDebtCurrent ▇▇█▆█▆▇▇▆▇███▇█▆▃▃▃▄▄▅▅▄▄▄▄▆▆▆█▆▁▂▁▆▆▅▃2261.02259.02757.01498.02999.01999.02499.02498.01999.02498.02748.02746.02998.02497.02747.01747.00.00.00.0700.0700.0953.0983.0331.0352.0442.0483.01477.0191572.0071871.7382696.971457.322-1488.17-942.759-1169.4331730.8381972.7631350.00.0NANANANANANANANANANANA
us-gaap:OperatingLeaseLiabilityCurrent NANA107.0NANANA99.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAccruedLiabilitiesCurrent █▇▇█▇▅▇▆▇▅▆▅▅▅▆▅▅▄▅▆▅▆▅▅▄▄▄▃▄▃▂▂▂▂▁▁2498.02274.02287.02550.02280.01808.02188.02118.02152.01838.02029.01818.01856.01711.01918.01744.01829.01589.01621.02084.01657.01936.01841.01623.01510.01440.01452.01224.8641443.3771222.8211023.938816.748831.399819.009674.762647.604NANA471.129NANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:LongTermDebt ▁▁█30175.030166.030500.0NANANANANANANANA27316.029060.0NA33542.0NANANANANANANA22178.0NANA12363.012404.09410.0599504.5439803.776635.6787313.4157337.7227997.5558223.9888771.22NANA7605.734NANANANANANANANANANANA
us-gaap:LongTermDebtNoncurrent ▇▇▇▇▅▆▆▆▆▆▆▆▇▇█▇▇▇▇▇▆▅▅▆▃▃▃▂▂▂▁▁▁▂▂▂▂▂▂27914.027907.028645.027792.021103.022098.022094.022090.024084.024080.024574.024570.026062.026557.030795.027515.026296.026321.026346.026371.021427.021077.021195.021894.011922.011921.011921.07933.047932.5367932.0323938.7085856.0935849.5527054.7967054.5557040.3827126.3778077.2467605.734NANANANANANANANANANANA
us-gaap:DeferredIncomeTaxLiabilitiesNet ▇█▁4374.04464.03914.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:MinorityInterest ▁▁▁▁▂▂▂▂▂▃▃▃▂▂▂▆▆▆▆▇███▇▅▆▅▄▅▅▅▄▄▄▄▃▂▁▂▂▃▄▄7.012.019.026.0115.0112.0125.0132.0135.0140.0147.0146.062.060.059.0409.0414.0476.0476.0492.0579.0621.0579.0530.0347.0408.0393.0297.387338.713314.872375.434308.863251.384240.242241.13146.5281.26750.472128.493116.442164.486229.108258.108NANANA138.093NANANA
us-gaap:OtherLiabilitiesNoncurrent ▃▃█▂▂▂▂▂▃▃▂▂▂▂▂▁▂▁▁▁▂▁▂▁▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁1176.01430.05128.01086.01018.0990.01009.0901.01577.01460.01040.0594.0646.0671.0558.0259.0442.0333.0296.0184.0467.0374.0395.0378.0760.0619.0535.0482.542174.196174.945156.647261.091224.627213.327228.04221.646155.195153.991147.736138.774156.39149.79827.401NANANA35.918NANANA
us-gaap:OperatingLeaseLiabilityNoncurrent NANA608.0NANANA626.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo NANA122.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree NANA112.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour NANA97.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive NANA70.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive NANA300.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:StockholdersEquity ▆▆▆▅▅▇▇▆▇▇▇▇▇▆▆█▇▆▆▅▅▄▆▅▅▅▅▄▅▄▃▃▃▃▂▂▂▂▁▁▁▁▁19703.018952.018202.017445.018027.022067.022525.020604.022616.021951.021387.022861.021672.020591.020442.024845.022677.020441.018887.016868.015536.013398.018534.017414.016287.017180.015426.013566.22316090.62913387.32211369.06710883.6111092.010152.2319309.7398603.6428002.127313.6126738.8566116.7646046.8455946.2535863.729NANANA6367.065NANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▆▆▅▅▅▇▇▆▇▇▇▇▇▆▆█▇▆▆▅▅▄▆▅▅▅▅▄▅▄▃▃▃▃▂▂▂▁▁▁▁▁▁19710.018964.018221.017471.018142.022179.022650.020736.022751.022091.021534.023007.021734.020651.020501.025254.023091.020917.019363.017360.016115.014019.019113.017944.016634.017588.015819.013863.6116429.34213702.19411744.50111192.47311343.38410392.4739550.8698750.1628083.3877364.0846867.3496233.2066211.3316175.3616121.837NANANA6505.158NANANA
us-gaap:CommonStockValue ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂█▂█▅▅▅▅▁▁▁▁▁▁▁▁▁▁▁▁1.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.02.01.02.01.5141.5261.5381.5340.7630.7650.760.760.7580.7560.7580.7530.7570.7770.7910.802NANANA0.9NANANA
us-gaap:AdditionalPaidInCapital ▆▆▆▅▅▅▅▄▄▄▄▃▃▃▂▂▂▂▂▁▂▂▂▁▁▄▄▄██▇▇███▇▇▇▇▇▇▇▆4271.04092.03880.03712.03511.03311.03051.02870.02684.02494.02282.02118.01844.01564.01264.0906.0733.0616.0454.0321.0632.0516.0444.0285.00.02724.02391.02143.0925930.9875746.5745386.7355189.5825995.0255829.1265649.855435.2425213.915100.6244903.1434809.7524783.4394726.3094648.286NANANA4376.651NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ▅▅▅▅▅▆▇▆▇▇▇▇▇▇▇█▇▇▆▆▅▅▆▆▆▅▅▄▄▃▃▂▂▂▂▂▁▁▁▁▁▁▁15392.014821.014381.013709.014445.018709.019388.017616.019829.019326.019024.020706.019825.019196.019012.023689.021823.019564.018154.016654.014949.013045.018001.016961.016038.013916.012732.011247.65510199.5767734.9796105.2445735.3355065.8394301.5393704.7443139.3932663.0772178.6391776.761321.7961395.9081320.3351183.73NANANA1995.272NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▃▃▂▃▃▃▄▄▄▄▃▃▃▁▄▅▄▅▅▂▂▁▄▄▅█▆▄▂▂▁▂▃▃▂▃▄▃▃▃▁▂▃39.038.0-60.023.070.046.085.0117.0102.0130.080.036.02.0-170.0165.0249.0120.0260.0278.0-108.0-46.0-164.088.0167.0247.0539.0301.0173.962-41.46-95.769-124.446-42.0730.37120.806-45.61528.249124.37733.59158.2-15.541-133.279-101.18230.911NANANA-5.758NANANA
us-gaap:MinorityInterest ▁▁▁▁▂▂▂▂▂▃▃▃▂▂▂▆▆▆▆▇███▇▅▆▅▄▅▅▅▄▄▄▄▃▂▁▂▂▃▄▄7.012.019.026.0115.0112.0125.0132.0135.0140.0147.0146.062.060.059.0409.0414.0476.0476.0492.0579.0621.0579.0530.0347.0408.0393.0297.387338.713314.872375.434308.863251.384240.242241.13146.5281.26750.472128.493116.442164.486229.108258.108NANANA138.093NANANA
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue ▃▃▃▄▃▃▃▃▄▃▄▄▆▅█▂▁▁▁▁▁▁▁▁168.0140.0160.0173.0168.0141.0159.0160.0175.0144.0175.0190.0253.0224.0313.0114.0102.089.0103.095.095.088.099.097.0NANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▃▄▃▃▄▂▄▄▃▂▄▃▂▃▄▄▅▄▅▆▇▆▇▆██▄▆▆▂▁▁▂▁▁▁▂▁▂▂▂▁▁▁▁▁2316.02610.01916.02250.02566.01436.02580.02899.02221.01444.02345.02212.01573.02270.02753.02694.03526.02925.03486.04330.04940.03913.04874.04096.05658.05701.03020.6674044.0224185.2931568.018726.787753.096953.004672.101705.728745.3681290.651452.969978.107897.106943.255820.542724.843739.422699.079670.569NANANANA
us-gaap:NetCashProvidedByUsedInInvestingActivities ▅▅▂▆▄▆▆▅▃▆▇▇██▁▅▄▆▅▄▄▅▅▄▄▅▆▅▅▆▆▆▆▆▆▅▅▁█▆▅▆▆▅▆▅-577.0-2042.0-8977.0-271.0-5023.0-344.0431.0-2095.0-6042.0-111.02735.02025.05241.04354.0-10016.0-2114.0-4246.0307.0-2675.0-3917.0-3284.0-2109.0-2438.0-4186.0-3552.0-2299.0-404.759-770.053-487.248-160.94216.41-8.032-55.477-407.25650.07-518.044-634.964-10743.1164440.336-80.32-469.79-300.381-407.816-1394.129932.972-1068.778NANANANA
us-gaap:NetCashProvidedByUsedInFinancingActivities ▄▄▅▇▅▄▄▄▄▄▄▄▄▂▆▆▄▄▄▆▄▁▃█▂▄▅▂▄▆▅▄▅▅▅▅▅▆▇▄▄▅▅▅▄▅-931.0-2477.0131.04124.0-874.0-2611.0-896.0-2515.0-1857.0-2366.0-1670.0-2901.0-1152.0-6595.03347.02170.0-880.0-1244.0-2295.02860.0-1516.0-8396.0-3544.06644.0-5341.0-2722.01233.876-5771.421-1371.5912884.136-845.059-942.233-557.648-199.001-509.851-307.514-474.8791855.593526.62-876.199-1371.962485.11-459.656270.45-1165.53616.032NANANANA
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect ▅▄▁█▃▄▆▄▂▄▇828.0-1932.0-6889.06140.0-3305.0-1580.02157.0-1766.0-5687.0-1013.03371.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:DeferredIncomeTaxExpenseBenefit ▁█-68.071.0NA-121.053.056.0NA-824.04.024.0NA12.0-37.035.0NA-11.080.058.0NA21.0-131.015.0NANANANANANANANANANANANANANANANANANA19.46220.546NANA-1.16431.06NANANANA
us-gaap:IncreaseDecreaseInAccountsPayable ▄▂▅▃▄▃▄▄▄▂▅▃▃▃▄▃▃▂▅▃▅▂▃▁█▄▂▄▃▃▃▃▄▄▃▃▅▄▅▃▅▅▂▃▅▅31.0-253.0214.0-21.0-4.0-109.081.024.035.0-201.0178.0-24.0-101.0-92.085.0-116.0-137.0-262.0162.0-48.0172.0-239.0-62.0-332.0562.058.0-214.40115.346-69.828-20.117-120.804-41.734.03930.792-28.973-84.156122.962107.652171.139-37.843119.534176.114-146.145-120.57120.535141.727NANANANA
us-gaap:IncreaseDecreaseInAccountsReceivable ▄▁▆▅▂▄▄▃▄▃▃▃▃▃▃▃▅▂▂▂▃▄▃▆▅▄█▂▄▆▄▄▃▄▃▄▃▄▄▄▄▄▃▄▄▄281.0-975.0837.0702.0-744.0376.0251.0-101.0100.0-32.0-113.0-90.0-176.0-101.0-281.0-355.0419.0-537.0-422.0-580.0-381.0191.0-213.0800.0462.0348.01751.03-505.425214.7751117.6288.99145.042-50.515231.781-37.15519.336-376.698196.531154.343-0.573114.09107.876-3.206109.778.467163.914NANANANA
us-gaap:IncreaseDecreaseInInventories ▃▄▅▃▃▃▄▃▃▃▄▅▃▃▅▄▃▃▆▅▄▃▆▃▆█▂▁▂▄▅▃▅▄▅▃▅▃▄▃▃▄▂▁▅▅25.069.0147.026.037.0-15.060.023.0-3.015.0119.0157.020.014.0174.065.09.05.0214.0177.083.014.0196.025.0264.0370.0-42.172-121.691-63.74884.611126.49315.794143.74757.109125.18211.552186.35726.83364.10922.0417.4797.174-67.073-89.28142.558174.985NANANANA
us-gaap:NetCashProvidedByUsedInOperatingActivities ▃▄▃▃▄▂▄▄▃▂▄▃▂▃▄▄▅▄▅▆▇▆▇▆██▄▆▆▂▁▁▂▁▁▁▂▁▂▂▂▁▁▁▁▁2316.02610.01916.02250.02566.01436.02580.02899.02221.01444.02345.02212.01573.02270.02753.02694.03526.02925.03486.04330.04940.03913.04874.04096.05658.05701.03020.6674044.0224185.2931568.018726.787753.096953.004672.101705.728745.3681290.651452.969978.107897.106943.255820.542724.843739.422699.079670.569NANANANA
us-gaap:NetIncomeLoss ▅▆▅▄▁▅▆▃▆▆▄▆▆▅▁▆▇▆▇▇▇▇████▇▆▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1522.01729.01551.0360.0-3339.01551.02696.0-1165.01880.01975.03.02097.01817.01538.0-3865.02718.03073.02702.03108.03330.03497.03566.04683.04600.04492.04333.03487.02731.2743655.5932227.41791.411788.606772.605722.186762.541675.505706.074437.531665.145741.124746.227651.141629.419704.876712.061854.901802.212673.033571.398589.112
us-gaap:ProfitLoss ▅▆▅▄▁▅▆▃▆▆▄▆▆▅▁▆▇▆▇▇▇▇████▇▆▇▆▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅▅1517.01722.01544.0353.0-3346.01538.02689.0-1168.01875.01968.03.02099.01819.01539.0-3836.02712.03069.02699.03099.03325.03497.03567.04685.04592.04497.04332.03462.02724.2633650.4852222.587786.742785.216767.618717.71758.959671.035711.564441.956661.759737.538742.459647.303626.365702.163709.127852.094799.393670.478569.145586.576
us-gaap:ShareBasedCompensation ▄▃▄▄▄▃▄▄▄▃▄▅▆▅█▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁166.0139.0161.0173.0168.0141.0157.0162.0174.0143.0175.0198.0252.0220.0334.0113.0102.089.0102.095.095.088.097.097.096.092.095.41799.30783.09582.18171.69162.57355.95361.76757.12754.46448.40348.73146.60346.1850.12549.4753.35151.80248.04746.841NANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities ▅▅▂▆▄▆▆▅▃▆▇▇██▁▅▄▆▅▄▄▅▅▄▄▅▆▅▅▆▆▆▆▆▆▅▅▁█▆▅▆▆▅▆▅-577.0-2042.0-8977.0-271.0-5023.0-344.0431.0-2095.0-6042.0-111.02735.02025.05241.04354.0-10016.0-2114.0-4246.0307.0-2675.0-3917.0-3284.0-2109.0-2438.0-4186.0-3552.0-2299.0-404.759-770.053-487.248-160.94216.41-8.032-55.477-407.25650.07-518.044-634.964-10743.1164440.336-80.32-469.79-300.381-407.816-1394.129932.972-1068.778NANANANA
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▁▃▃▂▂▃▄▄▄▆▆▃█▅119.0165.0181.0155.0143.0171.0203.0200.0185.0237.0248.0167.0297.0212.0NA129.0123.0118.0NA198.0204.0177.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities ▄▄▅▇▅▄▄▄▄▄▄▄▄▂▆▆▄▄▄▆▄▁▃█▂▄▅▂▄▆▅▄▅▅▅▅▅▆▇▄▄▅▅▅▄▅-931.0-2477.0131.04124.0-874.0-2611.0-896.0-2515.0-1857.0-2366.0-1670.0-2901.0-1152.0-6595.03347.02170.0-880.0-1244.0-2295.02860.0-1516.0-8396.0-3544.06644.0-5341.0-2722.01233.876-5771.421-1371.5912884.136-845.059-942.233-557.648-199.001-509.851-307.514-474.8791855.593526.62-876.199-1371.962485.11-459.656270.45-1165.53616.032NANANANA
us-gaap:RepaymentsOfLongTermDebt ▁█0.01250.0NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RepaymentsOfLongTermDebt us-gaap:DebtInstrument,us-gaap:SubsequentEventType gild:A440SeniorUnsecuredNotesDueDecember2021,us-gaap:SubsequentEventNANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RepaymentsOfLongTermDebt us-gaap:StatementScenario,us-gaap:DebtInstrument srt:ScenarioForecast,gild:A440SeniorUnsecuredNotesDueDecember2021NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PaymentsOfDividends ██████▇▇▇▇▇▇▇▇▆▆▆▆▆▆▆▅▆▆▆▁▁▁894.0917.0858.0861.0856.0874.0801.0804.0800.0817.0736.0742.0740.0753.0682.0682.0680.0687.0619.0623.0626.0587.0614.0627.0633.00.00.00.0NANANANANANANANANANANANANANANANANANANANANANA
us-gaap:Dividends ██▇▇▇▇▆▆▆▆▄▄▅▅▃▃▃▃▂▂▂▁▂▂▂903.0906.0865.0866.0866.0867.0808.0807.0810.0814.0741.0746.0747.0752.0687.0685.0685.0685.0622.0625.0631.0587.0620.0631.0639.0NANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PaymentsForRepurchaseOfCommonStock ▁▁▁▁▁▂▁▁▂▂▂▁▁▂▁▁▁▁▂▂▂█▄▄▂▄▃▂▂▁▁▁▁▁▁▁▁▁▁▂▂▁▂▂▂▁43.0309.00.0201.054.01328.0105.0222.0588.0834.0962.0449.0450.01039.0106.0153.0130.0565.01000.01000.01001.08000.03051.03050.0900.03001.02000.5231700.01200.0450.087400.099100.020.082.239200.041205.209241.02120.77226.302883.968724.163548.699615.5381552.9741691.561162.52NANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.02000000.01000000.02000000.01514000.01526000.01538000.01534000.0763000.0765000.0760000.0760000.0758000.0756000.0758000.0753000.0757000.0777000.0791000.0802000.0900000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Shares Issued

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesIssued


Common
Period End2021-06-302020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1254125412541254126612661267127412821294129613001308130713061307131013221331134814221449147314771499151315261537153415341528152415197577567587537567760.79147801899
Percentage of CommonStockSharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Common Stock Shares Authorized

us-gaap:CommonStockSharesAuthorized

us-gaap:CommonStockSharesAuthorized


Common
Period End2021-06-302020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value56005600560056005600560056005600560056005600560056005600560056005600560056005600560056005600560056005600560056005600560056002800280028002800280028002.828002.828002800
Percentage of CommonStockSharesAuthorized100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Preferred Stock Shares Authorized

us-gaap:PreferredStockSharesAuthorized

us-gaap:PreferredStockSharesAuthorized


Preferred
Period End2021-06-302020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value5000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000000.05000.05000000.05000000.0
Percentage of PreferredStockSharesAuthorized100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Common Stock Shares Outstanding

us-gaap:CommonStockSharesOutstanding

us-gaap:CommonStockSharesOutstanding


Common
Period End2021-06-302020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1254125412541254126612661267127412821294129613001308130713061307131013221331134814221449147314771499151315261537153415341528152415197577567587537567760.79147801899
Percentage of CommonStockSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommonStockSharesOutstanding us-gaap:StatementEquityComponents

us-gaap:CommonStock


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-312013-12-31
Value125412541254125312541254126612661267127412821294129613001308130713061307131013221331134814221449147314991534
Percentage of CommonStockSharesOutstanding100.00.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding


Weighted
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value12601262126112551270126712771283130713081320131913171320133913551412150315401569163616641679169116941665792780777781800811847898928
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic


Weighted
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value12551256125512551262126712701276129612981307130613071308132213351383146314721488151315321536153215261521757756756767784796833881901
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount


Antidilutive
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value19151338144017161221129.0139.04.04.01.01.01.01.11.10.70.11.01.32.19.210212122272318
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareBasic


Earnings
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value1.211.381.240.29-2.661.232.13-0.921.481.5501.621.41.18-2.962.082.352.072.362.522.622.583.263.143.052.912.321.82.391.450.520.510.510.470.50.890.940.580.880.970.950.820.780.850.810.950.890.750.630.65
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EarningsPerShareBasic us-gaap:BusinessAcquisition

gild:ImmunomedicsInc


Earnings
Period End2020-12-31
Value0.49
Percentage of EarningsPerShareBasic39.5

us-gaap:EarningsPerShareBasic us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

gild:ArcusBiosciencesIncPionyrImmunotherapeuticsIncTangoAndTizona


Earnings
Period End2020-09-30
Value0.82
Percentage of EarningsPerShareBasic282.8

us-gaap:EarningsPerShareBasic us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:Galapagos, gild:GalapagosSubscriptionAgreement


Earnings
Period End2020-12-312020-09-302019-09-30
Value0.50.782.4
Percentage of EarningsPerShareBasic40.3269.0-260.9

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareDiluted


Earnings
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value1.211.371.230.29-2.661.222.12-0.921.471.5401.61.391.17-2.962.062.332.052.342.492.582.533.183.062.922.762.181.672.21.330.470.470.460.430.470.850.910.570.870.950.930.80.760.830.790.920.870.720.610.63
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EarningsPerShareDiluted us-gaap:BusinessAcquisition

gild:ImmunomedicsInc


Earnings
Period End2020-12-31
Value0.49
Percentage of EarningsPerShareDiluted39.8

us-gaap:EarningsPerShareDiluted us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

gild:ArcusBiosciencesIncPionyrImmunotherapeuticsIncTangoAndTizona


Earnings
Period End2020-09-30
Value0.82
Percentage of EarningsPerShareDiluted282.8

us-gaap:EarningsPerShareDiluted us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:Galapagos, gild:GalapagosSubscriptionAgreement


Earnings
Period End2020-12-312020-09-302019-09-30
Value0.50.782.4
Percentage of EarningsPerShareDiluted40.7269.0-260.9

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value152318271468313-3315.015122664-1150.01852202547213119891496-3949.0284729332684349432683615331446044520420045713613294637092256709716782788688579796417750855710515661520815941
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.528.419.84.8-64.527.345.3-20.532.638.30.838.135.229.4-66.443.741.141.347.743.646.542.554.154.550.960.249.448.856.845.122.725.728.331.226.623.933.118.334.140.333.226.733.126.842.345.1

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-03-312011-12-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value-5.0-7.0-7.0-7.0-7.0-13.0-7.0-3.0-5.0-7.00.02.02.01.029-6.0-4.0-3.0-9.0-5.00.01.02.0-8.05.0-1.0-25.058-7.011-5.108-4.823-4.669-3.39-4.987-4.476-4.425-3.386-3.586-3.768-3.838-2.713-2.934-2.807
Percentage of ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.1-0.1-0.1-0.1-0.2-0.1-0.1-0.1-0.10.00.00.00.00.5-0.1-0.1-0.0-0.1-0.10.00.00.0-0.10.1-0.0-0.3-0.1-0.1-0.1-0.1-0.1-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.1-0.2-0.1

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value151818201461306-3322.014992657-1153.01847201847213319911497-3920.0284129292681348532633615331546064512420545703588293937042251704712777784685574802417724858714519641522818944
Percentage of ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.428.319.74.7-64.627.045.2-20.632.538.20.838.135.329.4-65.943.641.041.247.643.546.542.554.254.451.060.249.148.756.745.022.625.628.131.026.523.733.418.332.940.533.426.932.127.042.545.3

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold

us-gaap:CostOfGoodsAndServicesSold


Cost
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value139013611398114110649691683103510009571570108611961001125610321126
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax22.421.218.817.320.717.528.618.517.618.127.119.421.219.721.115.815.8

Costs And Expenses

us-gaap:CostsAndExpenses

us-gaap:CostsAndExpenses


Costs
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value3971353347704576812631464786707732553044465129733368293536582700288727383275310132383143288527102628222329832562212219561922163416131506148113821346148213321117112010241169958934924
Percentage of CostsAndExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax63.955.064.369.6158.056.781.4126.357.357.680.353.159.657.761.541.540.442.144.741.341.640.333.932.731.929.340.842.432.539.161.658.858.359.557.257.056.064.960.652.752.453.258.549.548.544.3

Gross Profit

us-gaap:GrossProfit

us-gaap:GrossProfit


Gross
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value593053524003449841134481460742434111436943444000458153705920542061416276678764887347714771286523615949815488405821852027197217591834176017031627154815331505138914331387135013471330123911851118
Percentage of GrossProfit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax79.981.477.881.170.080.081.080.370.978.176.978.677.082.582.983.383.983.787.383.286.486.286.585.984.282.484.081.270.172.971.369.570.972.670.871.370.472.370.572.171.771.670.164.665.568.872.073.1

Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value181722641814825-2973.020031901-1501.0241023501016266420862033212636714115361739204276439945025437547255115239422933704307294811121079107594010229519696688189749828747999619931159
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax29.235.224.412.5-57.836.132.3-26.842.444.517.547.636.940.035.756.457.655.653.657.056.657.863.966.066.869.057.855.865.959.035.738.838.937.139.539.240.329.337.246.046.045.440.049.651.555.6

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxExpenseBenefit


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value300542270472373465-788.0-333.05353821013565267494596295910469188219519029357528801014907767646656725326294307222263280263231157237240227173258284307
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.88.43.67.27.38.4-13.4-5.99.47.217.510.14.79.7100.214.714.614.111.212.711.612.08.810.612.311.910.510.710.014.510.510.611.18.810.211.511.010.17.111.211.211.88.713.414.714.8

Interest Expense

us-gaap:InterestExpense

us-gaap:InterestExpense


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value2562572672362402412432502482542572642662902972912692612652422272302301651401531301031027673737881858988977443464140331716
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.14.03.63.64.74.34.14.54.44.84.44.74.75.75.04.53.84.03.63.22.93.02.72.01.72.01.81.71.61.52.32.72.83.23.33.73.74.33.42.02.22.12.01.70.90.8

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value152217291551360-3339.015512696-1165.0188019753.0209718171538-3865.0271830732702310833303497356646834600449243333487273136552227791788772722762675706437665741746651629704712854802673571589
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.526.920.95.5-64.928.045.9-20.833.137.40.137.532.230.2-65.041.743.041.542.544.445.045.855.155.554.557.147.745.255.944.625.428.327.928.529.527.829.419.230.234.934.933.831.536.436.941.039.537.434.738.5

Net Income Loss Attributable To Noncontrolling Interest

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-5.0-7.0-7.0-7.0-7.0-13.0-7.0-3.0-5.0-7.00.02.02.01.029-6.0-4.0-3.0-9.0-5.00.01.02.0-8.05.0-1.0-25.058-7.011-5.108-4.823-4.669-3.39-4.987-4.476-3.582-4.47-5.494.42525-3.586-3.768-3.838-3.054-2.713-2.934-2.807
Percentage of NetIncomeLossAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.1-0.1-0.1-0.1-0.2-0.1-0.1-0.1-0.10.00.00.00.00.5-0.1-0.1-0.0-0.1-0.10.00.00.0-0.10.1-0.0-0.3-0.1-0.1-0.1-0.1-0.1-0.2-0.2-0.1-0.2-0.20.21.2-0.2-0.2-0.2-0.2-0.1-0.2-0.1

Nonoperating Income Expense

us-gaap:NonoperatingIncomeExpense

us-gaap:NonoperatingIncomeExpense


Nonoperating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-173.0-369.0-570.0-940.0250-158.010512222283671293057217013215013011114011988814652352129-5.037-3.645-17.912-11.1085.777-0.231-3.3241.386-3.505-1.075-34.0852614111310151815
Percentage of NonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.8-5.7-7.7-14.34.9-2.817.94.04.06.92.25.51.33.32.22.31.81.71.91.61.11.00.50.60.40.30.4-0.1-0.1-0.4-0.40.2-0.0-0.10.1-0.1-0.0-1.51.20.70.60.70.50.80.90.8

Operating Income Loss

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value2246289026512001-2983.024021093-1473.024302237114426232280215322913812425437674045439945384651562155855616537143303479441230421197114711531025110610431059800867100310169018299799921161
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax36.145.035.730.4-58.043.318.6-26.342.742.419.746.940.442.338.558.559.657.955.358.758.459.766.167.368.170.759.257.667.560.938.441.241.740.542.843.044.035.139.447.347.646.841.550.551.555.7

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value7.090-69.0-57.0-52.034-57.038-34.0-1.0472.0163-13.06.0-51.0-102.0
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.11.4-0.9-0.9-1.00.6-1.00.7-0.6-0.00.80.02.9-0.30.1-0.8-1.4

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-30
Value-5.010.010.0234.0-39.025-27.0-13.021-21.01.0-25.07.04.0-4.029-76.0216-50.09.02.0133.03.0-10.0-5.938-10.0311.1865.783-49.5952.38111-8.9563.735.09-2.6424.897-4.142-3.958-4.358
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.10.20.10.30.1-0.70.4-0.5-0.20.4-0.40.0-0.40.10.1-0.10.4-1.23.0-0.70.10.00.20.00.0-0.1-0.1-0.20.00.1-1.60.10.4-0.40.10.2-0.10.2-0.2-0.2-0.2

Other Comprehensive Income Loss Net Of Tax

us-gaap:OtherComprehensiveIncomeLossNetOfTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-30
Value1.098-83.0-47.024-39.0-32.015-28.0504434172-42.0-84.0129-140.0-18.0386-62.0118-252.0-79.0-80.0-292.02381262155428-82.376-72.4419.56566-73.864-96.12890-24.60973117
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.01.5-1.1-0.70.5-0.7-0.50.3-0.50.90.80.63.0-0.8-1.42.0-2.0-0.35.3-0.81.5-3.2-0.9-1.0-3.53.11.73.60.80.6-2.6-2.60.32.6-2.9-4.03.8-1.13.45.5

us-gaap:OtherComprehensiveIncomeLossNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent


Other
Period End2021-06-302021-03-312020-06-302020-03-31
Value7.090-52.034
Percentage of OtherComprehensiveIncomeLossNetOfTax700.091.8-216.7-87.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.11.4-1.00.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedGainLossNetCashFlowHedgeParent0.00.00.00.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges


Other
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312014-12-312014-09-302014-06-302014-03-312013-06-302013-03-31
Value-69.0-57.0-52.034-57.038-35.0-1.0472.0150-13.06.0-51.0-102.0-129.03211332265122-0.08873
Percentage of OtherComprehensiveIncomeLossNetOfTax83.1121.3-216.7-87.2178.1253.3125.0-2.0106.85.987.231.0-7.1-39.572.9716.783.2105.1105.195.180.0-0.9110.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.9-0.9-1.00.6-1.00.7-0.6-0.00.80.02.7-0.30.1-0.8-1.4-2.04.41.83.70.80.5-0.02.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312014-12-312014-09-302014-06-302014-03-312013-06-302013-03-31
Value-1.0-2.0-24.0-13.072-34.00.04.049301831-2.0-36.0-94.0184-67.0187-151.0-0.558-0.8821.492-0.052-2.0771.768
Percentage of OtherComprehensiveIncomeLossNetOfTax-100.0-2.028.927.7300.087.2-0.026.7-175.060.040.991.2-1.285.7111.9142.647.9-1038.9-39.1-0.4-0.42.7-0.2-21.72.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.0-0.0-0.3-0.21.4-0.60.00.10.90.60.30.6-0.0-0.7-1.62.8-0.92.9-2.1-0.0-0.00.0-0.0-0.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value1.098-83.0-47.024-39.0-32.015-28.0504434172-42.0-84.0129-140.0-18.0386-62.0118-252.0-79.0-80.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.01.5-1.1-0.70.5-0.7-0.50.3-0.50.90.80.63.0-0.8-1.42.0-2.0-0.35.3-0.81.5-3.2-0.9-1.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value-5.010.010.0234.0-39.025-27.08.021-21.01.0-18.07.04.0-4.029-76.0216-5.938-10.0311.1865.783-49.5952.38111-8.956
Percentage of OtherComprehensiveIncomeLossNetOfTax-500.010.2-12.0-48.916.7100.0-78.1-180.0-28.642.0-47.72.9-10.5-16.7-4.8-3.1-20.7422.256.0-4.7-4.72.220.260.2-3.3122.6-13.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.10.20.10.30.1-0.70.4-0.50.10.4-0.40.0-0.30.10.1-0.10.4-1.23.0-0.1-0.20.00.1-1.60.10.4-0.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Other
Period End2020-12-312020-09-30
Value0.01.0
Percentage of OtherComprehensiveIncomeLossNetOfTax-0.0-2.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AdditionalPaidInCapital0.00.0

us-gaap:RetainedEarnings


Other
Period End2020-12-312020-09-30
Value0.0-1.0
Percentage of OtherComprehensiveIncomeLossNetOfTax-0.02.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.0

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value151717221544353-3346.015382689-1168.0187519683.0209918191539-3836.0271230692699309933253497356746854592449743323462272436502222786785767717758671711441661737742647626702709852799670569586
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.426.820.85.4-65.127.745.7-20.833.037.30.137.532.230.2-64.541.643.041.542.344.345.045.855.155.454.557.047.345.155.944.525.228.227.728.329.327.729.619.430.134.834.733.631.336.236.840.939.337.234.638.3

us-gaap:ProfitLoss us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value-5.0-7.0-7.0-7.0-7.0-13.0-7.0-3.0-5.0-7.00.02.02.01.029-6.0-4.0-3.0-9.0-5.00.01.02.0-8.0
Percentage of ProfitLoss-0.3-0.4-0.5-2.00.2-0.8-0.30.3-0.3-0.40.00.10.10.1-0.8-0.2-0.1-0.1-0.3-0.20.00.00.0-0.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.1-0.1-0.1-0.1-0.2-0.1-0.1-0.1-0.10.00.00.00.00.5-0.1-0.1-0.0-0.1-0.10.00.00.0-0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value152217291551360-3339.015512696-1165.0188019753.0209718171538-3865.0271830732702310833303497356646834600
Percentage of ProfitLoss100.3100.4100.5102.099.8100.8100.399.7100.3100.4100.099.999.999.9100.8100.2100.1100.1100.3100.2100.0100.0100.0100.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.526.920.95.5-64.928.045.9-20.833.137.40.137.532.230.2-65.041.743.041.542.544.445.045.855.155.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Research And Development Expense Excluding Acquired In Process Cost

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost


Research
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value11341055157811581299100410991030995439465396458402290282254392230231218
Percentage of ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax18.216.421.317.625.318.118.718.417.517.019.216.520.118.313.713.213.219.711.912.010.5

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value62176423742165775143554858795604568552815795559656485088594965127141650573207500777677948506829582447594731460416534499831192782276725312588242624052282220021212137192619981937192720852032180116471530
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

gild:COVID19ProductsVeklury


Revenue
Period End2020-12-312020-09-30
Value1938873
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax26.113.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax26.113.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:COVID19ProductsVeklury100.0100.0

gild:CallTherapyProductsTecartus


Revenue
Period End2021-03-31
Value31
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CallTherapyProductsTecartus100.0

gild:CellTherapyProductsTecartus


Revenue
Period End2021-06-302020-06-30
Value411.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTecartus100.0100.0

gild:CellTherapyProductsTotalCellTherapyProductSales


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value219191157140
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.03.12.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.03.12.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTotalCellTherapyProductSales100.0100.0100.0100.0

gild:CellTherapyProductsYescarta


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value178160156140
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.92.53.02.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.92.53.02.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsYescarta100.0100.0100.0100.0

gild:HCVProductSales


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value549510448729
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.87.98.713.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.87.98.713.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductSales100.0100.0100.0100.0

gild:HCVProductsLedipasvirSofosbuvir


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value62569.08467112101124193225232311331348
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.90.11.31.32.01.72.23.44.34.05.65.96.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.90.11.31.32.01.72.23.44.34.05.65.96.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsLedipasvirSofosbuvir100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsSofosbuvirVelpatasvir


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value442381370330335564465516493491453477500536
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.15.95.05.06.510.27.99.28.79.37.88.58.910.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.15.95.05.06.510.27.99.28.79.37.88.58.910.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsSofosbuvirVelpatasvir100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsVosevi


Revenue
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4539485663756377103109107
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.80.91.01.11.31.21.31.81.92.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.80.91.01.11.31.21.31.81.92.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsVosevi100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductSales


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value3938365040004134
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax63.356.877.874.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax63.356.877.874.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductSales100.0100.0100.0100.0

gild:HIVProductsAtripla


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value60313811310395128149152171285258349314
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.50.51.72.01.72.22.72.73.24.94.66.26.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.50.51.72.01.72.22.72.73.24.94.66.26.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsAtripla100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsBiktarvy


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value19941824207118911604169315701259111679357838618535
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax32.128.427.928.831.230.526.722.519.615.010.06.93.30.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax32.128.427.928.831.230.526.722.519.615.010.06.93.30.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsBiktarvy100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsCompleraEviplera


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value6263517072767593123115125139199190
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.01.00.71.11.41.41.31.72.22.22.22.53.53.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.01.00.71.11.41.41.31.72.22.22.22.53.53.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsCompleraEviplera100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsDescovy


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value435359478508417458437363358342411406403361
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.05.66.47.78.18.37.46.56.36.57.17.37.17.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.05.66.47.78.18.37.46.56.36.57.17.37.17.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsDescovy100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsGenvoya


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value70667385284681682495897898010151206117611601082
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.410.511.512.915.914.916.317.517.219.220.821.020.521.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.410.511.512.915.914.916.317.517.219.220.821.020.521.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsGenvoya100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsOdefsey


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value382367444437382409435436387397448423385342
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.15.76.06.67.47.47.47.86.87.57.77.66.86.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.15.76.06.67.47.47.47.86.87.57.77.66.86.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsOdefsey100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsStribild


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value514642425953719410896137146187174
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.70.60.61.11.01.21.71.91.82.42.63.33.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.70.60.61.11.01.21.71.91.82.42.63.33.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsStribild100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsTruvada


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value108135146509387406768721718606823757765652
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.72.12.07.77.57.313.112.912.611.514.213.513.512.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.72.12.07.77.57.313.112.912.611.514.213.513.512.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsTruvada100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProduct


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value237220219186
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.83.44.33.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.83.44.33.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProduct100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductOther


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value9.08.03.010.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductOther100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value200181151136
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.22.82.92.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.22.82.92.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductViread


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value28316540
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.51.30.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.51.30.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductViread100.0100.0100.0100.0

gild:OtherHepatitisCVirusProducts


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value45734653
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.71.10.91.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.71.10.91.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherHepatitisCVirusProducts100.0100.0100.0100.0

gild:OtherProductsAmBisome


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value156121111111951191109910593108102103107909292
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.51.91.51.71.82.11.91.81.81.81.91.81.82.11.51.41.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.51.91.51.71.82.11.91.81.81.81.91.81.82.11.51.41.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsAmBisome100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsLetairis


Revenue
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value575478808396121204197254241244204233213230
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.81.21.61.51.62.23.63.74.44.34.34.03.93.33.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.81.21.61.51.62.23.63.74.44.34.34.03.93.33.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsLetairis100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsOther


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value5448296160635825140623564115106177273368
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.70.40.91.21.11.00.42.51.20.61.12.02.13.04.25.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.70.40.91.21.11.00.42.51.20.61.12.02.13.04.25.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsOther100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsRanexa


Revenue
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value2.03.00.01.08.0113119155177178208195200164200
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.10.20.60.32.93.13.23.73.83.42.52.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.10.20.60.32.93.13.23.73.83.42.52.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsRanexa100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsTotalOtherProductSales


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value291241243278
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.73.84.75.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.73.84.75.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsTotalOtherProductSales100.0100.0100.0100.0

gild:OtherProductsVemlidy


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value193177151136137134116101100877658
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.72.92.52.32.42.01.91.71.61.31.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.72.92.52.32.42.01.91.71.61.31.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsVemlidy100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsViread


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value483265403957757258708297
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.51.30.70.71.01.31.41.01.31.51.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.51.30.70.71.01.31.41.01.31.51.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsViread100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsYescarta


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value12913815614012211812096817568407.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.72.13.02.52.12.12.11.81.41.31.20.80.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.72.13.02.52.12.12.11.81.41.31.20.80.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsYescarta100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

gild:OtherProductsZydelig


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value2215171718202426262741203933394035
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.20.20.30.30.40.40.50.50.50.70.40.70.60.70.60.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.20.20.30.30.40.40.50.50.50.70.40.70.60.70.60.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsZydelig100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:ProductsOtherHIV


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value11179.013288.010.05.0151715141913171511
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.30.10.20.50.10.20.10.30.30.30.30.30.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.30.10.20.50.10.20.10.30.30.30.30.30.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsOtherHIV100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:ProductsRevenueShareSymtuza


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value12913512611813211212510484663722137.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.12.11.71.82.62.02.11.91.51.20.60.40.20.10.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.12.11.71.82.62.02.11.91.51.20.60.40.20.10.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsRevenueShareSymtuza100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

gild:RoyaltyContractAndOther


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value658393847681838878811141411088711211095
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.01.31.31.31.51.51.41.61.41.52.02.51.91.71.91.71.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.01.31.31.31.51.51.41.61.41.52.02.51.91.71.91.71.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:Trodelvy


Revenue
Period End2021-06-302021-03-31
Value8972
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:Trodelvy100.0100.0

gild:Veklury


Revenue
Period End2021-06-302021-03-31
Value8291456
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.322.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.322.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:Veklury100.0100.0

us-gaap:Product


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value61526340732864935067546757965516560752005681545555405001583764027046
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax99.098.798.798.798.598.598.698.498.698.598.097.598.198.398.198.398.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax99.098.798.798.798.598.598.698.498.698.598.097.598.198.398.198.398.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:StatementGeographical

gild:COVID19ProductsVeklury, country:US


Revenue
Period End2020-12-312020-09-30
Value1241785
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.711.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.711.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:COVID19ProductsVeklury country:US100.0100.0

gild:COVID19ProductsVeklury, gild:OtherInternational


Revenue
Period End2020-12-312020-09-30
Value15028
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.00.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.00.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:COVID19ProductsVeklury gild:OtherInternational100.0100.0

gild:COVID19ProductsVeklury, srt:Europe


Revenue
Period End2020-12-312020-09-30
Value54760
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.40.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.40.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:COVID19ProductsVeklury srt:Europe100.0100.0

gild:CallTherapyProductsTecartus, country:US


Revenue
Period End2021-03-31
Value27
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CallTherapyProductsTecartus country:US100.0

gild:CallTherapyProductsTecartus, srt:Europe


Revenue
Period End2021-03-31
Value4.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CallTherapyProductsTecartus srt:Europe100.0

gild:CellTherapyProductsTecartus, country:US


Revenue
Period End2021-06-30
Value32
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTecartus country:US100.0

gild:CellTherapyProductsTecartus, srt:Europe


Revenue
Period End2021-06-302020-06-30
Value9.01.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTecartus srt:Europe100.0100.0

gild:CellTherapyProductsTotalCellTherapyProductSales, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value14011995103
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.31.91.81.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.31.91.81.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTotalCellTherapyProductSales country:US100.0100.0100.0100.0

gild:CellTherapyProductsTotalCellTherapyProductSales, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-30
Value9.07.05.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTotalCellTherapyProductSales gild:OtherInternational100.0100.0100.0

gild:CellTherapyProductsTotalCellTherapyProductSales, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value70655737
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.01.10.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.01.10.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsTotalCellTherapyProductSales srt:Europe100.0100.0100.0100.0

gild:CellTherapyProductsYescarta, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value1089295103
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.41.81.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.41.81.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsYescarta country:US100.0100.0100.0100.0

gild:CellTherapyProductsYescarta, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-30
Value9.07.05.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsYescarta gild:OtherInternational100.0100.0100.0

gild:CellTherapyProductsYescarta, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value61615637
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.10.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.10.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:CellTherapyProductsYescarta srt:Europe100.0100.0100.0100.0

gild:HCVProductSales, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value327258220398
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.34.04.37.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.34.04.37.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductSales country:US100.0100.0100.0100.0

gild:HCVProductSales, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value129117158183
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.11.83.13.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.11.83.13.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductSales gild:OtherInternational100.0100.0100.0100.0

gild:HCVProductSales, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value9313570148
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.52.11.42.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.52.11.42.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductSales srt:Europe100.0100.0100.0100.0

gild:HCVProductsLedipasvirSofosbuvir, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3019-21.0362453555486117153185230234
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.3-0.30.50.51.00.91.01.52.22.63.34.14.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.3-0.30.50.51.00.91.01.52.22.63.34.14.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsLedipasvirSofosbuvir country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsLedipasvirSofosbuvir, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value2921273739483856858151887958
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.30.40.60.80.90.61.01.51.50.91.61.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.30.40.60.80.90.61.01.51.50.91.61.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsLedipasvirSofosbuvir gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsLedipasvirSofosbuvir, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3.0163.0114.0118.014222728382256
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.20.00.20.10.20.10.20.40.50.50.70.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.20.00.20.10.20.10.20.40.50.50.70.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsLedipasvirSofosbuvir srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsSofosbuvirVelpatasvir, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value262214218170165311240282219230201225239269
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.23.32.92.63.25.64.15.03.94.43.54.04.25.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.23.32.92.63.25.64.15.03.94.43.54.04.25.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsSofosbuvirVelpatasvir country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsSofosbuvirVelpatasvir, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value989268861131311001161181071001169369
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.40.91.32.22.41.72.12.12.01.72.11.61.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.40.91.32.22.41.72.12.12.01.72.11.61.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsSofosbuvirVelpatasvir gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsSofosbuvirVelpatasvir, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value8275847457122125118156154152136168198
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.21.11.11.12.22.12.12.72.92.62.43.03.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.21.11.11.12.22.12.12.72.92.62.43.03.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsSofosbuvirVelpatasvir srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsVosevi, country:US


Revenue
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3327333842534554788686
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.60.60.70.90.90.91.41.51.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.60.60.70.90.90.91.41.51.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsVosevi country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsVosevi, gild:OtherInternational


Revenue
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3.06.04.07.09.07.02.02.04.03.05.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.10.20.10.00.00.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.10.20.10.00.00.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsVosevi gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HCVProductsVosevi, srt:Europe


Revenue
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value9.06.0111112151621212016
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.20.20.20.30.30.40.40.40.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.20.20.20.30.30.40.40.40.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HCVProductsVosevi srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductSales, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value3044278632383253
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax49.043.463.058.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax49.043.463.058.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductSales country:US100.0100.0100.0100.0

gild:HIVProductSales, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value298286250242
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.84.54.94.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.84.54.94.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductSales gild:OtherInternational100.0100.0100.0100.0

gild:HIVProductSales, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value596578512639
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.69.010.011.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.69.010.011.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductSales srt:Europe100.0100.0100.0100.0

gild:HIVProductsAtripla, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value522332999581114132122133244221274228
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.40.41.51.81.51.92.42.12.54.23.94.94.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.40.41.51.81.51.92.42.12.54.23.94.94.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsAtripla country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsAtripla, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4.04.02.09.03.07.06.07.04.022298.03635
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.10.10.10.10.10.10.40.50.10.60.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.10.10.10.10.10.10.40.50.10.60.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsAtripla gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsAtripla, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4.04.04.05.05.07.08.010.0261612293951
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.10.10.20.50.30.20.50.71.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.10.10.20.50.30.20.50.71.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsAtripla srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsBiktarvy, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value15861465174915841350141213571106102373955137518335
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax25.522.823.624.126.225.523.119.718.014.09.56.73.20.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax25.522.823.624.126.225.523.119.718.014.09.56.73.20.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsBiktarvy country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsBiktarvy, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1711431151131011007245206.01.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.82.21.51.72.01.81.20.80.40.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.82.21.51.72.01.81.20.80.40.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsBiktarvy gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

gild:HIVProductsBiktarvy, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value237216207194153181141108734826112.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.83.42.82.93.03.32.41.91.30.90.40.20.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.83.42.82.93.03.32.41.91.30.90.40.20.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsBiktarvy srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

gild:HIVProductsCompleraEviplera, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value2025122627243440424466618267
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.40.20.40.50.40.60.70.70.81.11.11.51.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.40.20.40.50.40.60.70.70.81.11.11.51.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsCompleraEviplera country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsCompleraEviplera, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3.04.04.09.03.05.06.08.09.09.011111414
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.10.10.10.10.10.20.20.20.20.20.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.10.10.10.10.10.20.20.20.20.20.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsCompleraEviplera gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsCompleraEviplera, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value393435354247354572624867103109
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.50.50.50.80.80.60.81.31.20.81.21.82.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.50.50.50.80.80.60.81.31.20.81.21.82.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsCompleraEviplera srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsDescovy, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value357282402424337363343256246233322310311274
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.74.45.46.46.66.55.84.64.34.45.65.55.55.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.74.45.46.46.66.55.84.64.34.45.65.55.55.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsDescovy country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsDescovy, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value3435353534343944434115151412
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.70.60.70.80.80.80.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.70.60.70.80.80.80.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsDescovy gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsDescovy, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4442414946615563696874817875
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.70.60.70.91.10.91.11.21.31.31.41.41.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.70.60.70.91.10.91.11.21.31.31.41.41.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsDescovy srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsGenvoya, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value551506678669646612762761733728953921904853
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.97.99.110.212.611.013.013.612.913.816.416.516.016.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.97.99.110.212.611.013.013.612.913.816.416.516.016.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsGenvoya country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsGenvoya, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value5561606161615465709455524943
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.90.80.91.21.10.91.21.21.80.90.90.90.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.90.80.91.21.10.91.21.21.80.90.90.90.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsGenvoya gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsGenvoya, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value100106114116109151142152177193198203207186
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.71.51.82.12.72.42.73.13.73.43.63.73.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.71.51.82.12.72.42.73.13.73.43.63.73.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsGenvoya srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsOdefsey, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value258240321309273269315317266282337323303279
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.13.74.34.75.34.85.45.74.75.35.85.85.45.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.13.74.34.75.34.85.45.74.75.35.85.85.45.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsOdefsey country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsOdefsey, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value13141412111310.08.010.09.06.05.05.05.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.20.20.20.20.10.20.20.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.20.20.20.20.10.20.20.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsOdefsey gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsOdefsey, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value11111310911698127110111111106105957758
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.81.81.51.81.92.31.92.02.02.01.81.71.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.81.81.51.81.92.31.92.02.02.01.81.71.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsOdefsey srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsStribild, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value35312527393460637867117111144133
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.50.30.40.80.61.01.11.41.32.02.02.52.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.50.30.40.80.61.01.11.41.32.02.02.52.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsStribild country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsStribild, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value5.04.05.02.08.02.0-4.0136.0116.0159.012
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.00.20.0-0.10.20.10.20.10.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.00.20.0-0.10.20.10.20.10.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsStribild gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsStribild, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1111121312171518241814203429
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.20.20.30.30.30.40.30.20.40.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.20.20.30.30.30.40.30.20.40.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsStribild srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsTruvada, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value94119131492370383744688657551784665649507
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.91.87.57.26.912.712.311.610.413.511.911.510.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.91.87.57.26.912.712.311.610.413.511.911.510.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsTruvada country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsTruvada, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value8.09.08.01111151119202224303048
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.20.20.30.20.30.40.40.40.50.50.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.20.20.30.20.30.40.40.40.50.50.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsTruvada gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HIVProductsTruvada, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value6.07.07.06.06.08.01314413315628697
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.10.20.20.70.60.31.11.51.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.10.20.20.70.60.31.11.51.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HIVProductsTruvada srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProduct, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value90818085
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.31.61.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.31.61.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProduct country:US100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProduct, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value12311612281
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.01.82.41.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.01.82.41.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProduct gild:OtherInternational100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProduct, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value24231720
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.30.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.30.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProduct srt:Europe100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductOther, country:US


Revenue
Period End2021-06-302020-06-302020-03-31
Value1.01.08.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductOther country:US100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductOther, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value8.08.02.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductOther srt:Europe100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value86777673
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.21.51.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.21.51.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy country:US100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value106966856
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.51.31.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.51.31.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy gild:OtherInternational100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value8.08.07.07.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidy srt:Europe100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductViread, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value3.04.03.04.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductViread country:US100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductViread, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value17205425
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.31.00.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.31.00.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductViread gild:OtherInternational100.0100.0100.0100.0

gild:HepatitisBVirusHepatitisDeltaVirusProductViread, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value8.07.08.011
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:HepatitisBVirusHepatitisDeltaVirusProductViread srt:Europe100.0100.0100.0100.0

gild:OtherHepatitisCVirusProducts, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value35253134
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.40.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.40.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherHepatitisCVirusProducts country:US100.0100.0100.0100.0

gild:OtherHepatitisCVirusProducts, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value2.04.06.04.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherHepatitisCVirusProducts gild:OtherInternational100.0100.0100.0100.0

gild:OtherHepatitisCVirusProducts, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value8.0449.015
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.70.20.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.70.20.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherHepatitisCVirusProducts srt:Europe100.0100.0100.0100.0

gild:OtherProductsAmBisome, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1312151810.01810.09.010.08.06.09.014172.09.08.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.30.20.30.20.20.20.20.10.20.20.30.00.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.20.20.30.20.30.20.20.20.20.10.20.20.30.00.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsAmBisome country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsAmBisome, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value7443323536424033352843343434343234
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.20.70.40.50.70.80.70.60.60.50.70.60.60.70.60.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.20.70.40.50.70.80.70.60.60.50.70.60.60.70.60.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsAmBisome gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsAmBisome, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value6966645849596057605759595556545150
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.00.90.91.01.11.01.01.11.11.01.11.01.10.90.80.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.00.90.91.01.11.01.01.11.11.01.11.01.10.90.80.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsAmBisome srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsLetairis, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value57547378808396121204197254241244204233213230
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.81.01.21.61.51.62.23.63.74.44.34.34.03.93.33.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.90.81.01.21.61.51.62.23.63.74.44.34.34.03.93.33.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsLetairis country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsOther, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value2727223943423842413644372729557098
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.30.60.80.80.60.70.70.70.80.70.50.60.91.11.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.40.30.60.80.80.60.70.70.70.80.70.50.60.91.11.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsOther country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsOther, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value9.08.08.02.01.03.00.04.02.06.0-10.08.0476287170144
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.00.00.10.00.10.00.1-0.20.10.81.21.52.62.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.00.00.10.00.10.00.1-0.20.10.81.21.52.62.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsOther gild:OtherInternational100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsOther, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1813-1.020161820-21.097201.01941153533126
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.2-0.00.30.30.30.3-0.41.70.40.00.30.70.30.60.51.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.2-0.00.30.30.30.3-0.41.70.40.00.30.70.30.60.51.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsOther srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsRanexa, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value2.03.00.00.01.08.0113119155177178208195200164200
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.10.20.60.32.93.13.23.73.83.42.52.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.10.20.60.32.93.13.23.73.83.42.52.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsRanexa country:US100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsTotalOtherProductSales, country:US


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value107104137150
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.62.72.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.62.72.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsTotalOtherProductSales country:US100.0100.0100.0100.0

gild:OtherProductsTotalOtherProductSales, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value84513845
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.40.80.70.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.40.80.70.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsTotalOtherProductSales gild:OtherInternational100.0100.0100.0100.0

gild:OtherProductsTotalOtherProductSales, srt:Europe


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value100866883
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.31.31.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.31.31.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsTotalOtherProductSales srt:Europe100.0100.0100.0100.0

gild:OtherProductsVemlidy, country:US


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1089976739578716573665947
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.51.51.31.61.41.21.21.31.21.00.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.51.51.31.61.41.21.21.31.21.00.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsVemlidy country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsVemlidy, gild:OtherInternational


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value78706856365040322319148.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.11.31.00.60.90.70.60.40.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.11.31.00.60.90.70.60.40.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsVemlidy gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsVemlidy, srt:Europe


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value7.08.07.07.06.06.05.04.04.02.03.03.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.10.10.10.10.00.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.10.10.10.10.10.00.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsVemlidy srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsViread, country:US


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4.03.03.04.04.07.09.01210.017167.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.00.10.10.10.10.20.20.20.30.30.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.00.10.10.10.10.20.20.20.30.30.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsViread country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsViread, gild:OtherInternational


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value372154252335384638433460
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.31.00.50.40.60.70.90.70.80.61.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.31.00.50.40.60.70.90.70.80.61.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsViread gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsViread, srt:Europe


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value7.08.08.0111215281410.010.03230
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.20.20.20.30.50.30.20.20.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.20.20.20.30.50.30.20.20.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsViread srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsYescarta, country:US


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value79859510398869990807568407.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.31.81.91.71.51.71.71.41.31.20.80.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.31.81.91.71.51.71.71.41.31.20.80.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsYescarta country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

gild:OtherProductsYescarta, gild:OtherInternational


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value3.02.05.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.10.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.10.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsYescarta gild:OtherInternational100.0100.0100.00.00.00.00.00.00.00.00.00.00.00.00.0

gild:OtherProductsYescarta, srt:Europe


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value475156372432216.01.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.81.10.70.40.60.40.10.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.81.10.70.40.60.40.10.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsYescarta srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.00.0

gild:OtherProductsZydelig, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value8.08.07.08.08.08.01113121115151714171819
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.20.10.20.20.20.20.30.30.30.30.30.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.10.10.20.10.20.20.20.20.30.30.30.30.30.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsZydelig country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherProductsZydelig, gild:OtherInternational


Revenue
Period End2021-06-302020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1.01.00.01.00.01.00.00.01.00.01.00.01.02.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsZydelig gild:OtherInternational100.0100.00.0100.00.0100.00.00.0100.00.0100.00.0100.0100.00.00.0

gild:OtherProductsZydelig, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value137.09.09.09.01212131415264.02218202216
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.10.10.10.20.20.20.20.20.30.40.10.40.40.30.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.10.10.10.20.20.20.20.20.30.40.10.40.40.30.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherProductsZydelig srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:ProductsOtherHIV, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value5.06.01.010.0113.07.03.09.01110.010.0119.09.0137.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.20.20.10.10.10.20.20.20.20.20.20.20.20.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.20.20.10.10.10.20.20.20.20.20.20.20.20.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsOtherHIV country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:ProductsOtherHIV, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value2.010.07.02.0163.01.01.05.05.04.02.05.03.07.00.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.20.10.00.30.10.00.00.10.10.10.00.10.10.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.20.10.00.30.10.00.00.10.10.10.00.10.10.10.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsOtherHIV gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0

gild:ProductsOtherHIV, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value4.01.01.01.01.02.02.01.01.01.01.02.03.01.01.02.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.00.00.00.00.00.00.00.00.00.00.00.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.00.00.00.00.00.00.00.00.00.00.00.10.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsOtherHIV srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:ProductsRevenueShareSymtuza, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value86898782907284685542198.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.41.21.21.71.31.41.21.00.80.30.10.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.41.21.21.71.31.41.21.00.80.30.10.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsRevenueShareSymtuza country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.0

gild:ProductsRevenueShareSymtuza, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value3.02.02.02.02.02.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsRevenueShareSymtuza gild:OtherInternational100.0100.0100.0100.0100.0100.00.00.00.00.00.00.00.00.00.00.00.0

gild:ProductsRevenueShareSymtuza, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value404437344038413629241814137.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.70.50.50.80.70.70.60.50.50.30.30.20.10.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.70.50.50.80.70.70.60.50.50.30.30.20.10.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:ProductsRevenueShareSymtuza srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

gild:RoyaltyContractAndOther, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value2020212414171920192218201420232122
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.30.40.30.30.30.40.30.40.30.40.20.40.40.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.30.40.30.30.30.40.30.40.30.40.20.40.40.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:RoyaltyContractAndOther, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value0.02.01.00.00.0161.01.01.03.019191515151514
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.30.00.00.00.10.30.30.30.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.30.00.00.00.10.30.30.30.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther gild:OtherInternational0.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:RoyaltyContractAndOther, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value45617160624863675856771027952747459
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.91.00.91.20.91.11.21.01.11.31.81.41.01.21.10.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.91.00.91.20.91.11.21.01.11.31.81.41.01.21.10.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:Trodelvy, country:US


Revenue
Period End2021-06-302021-03-31
Value8972
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:Trodelvy country:US100.0100.0

gild:Veklury, country:US


Revenue
Period End2021-06-302021-03-31
Value416820
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.712.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.712.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:Veklury country:US100.0100.0

gild:Veklury, gild:OtherInternational


Revenue
Period End2021-06-302021-03-31
Value149248
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.43.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.43.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:Veklury gild:OtherInternational100.0100.0

gild:Veklury, srt:Europe


Revenue
Period End2021-06-302021-03-31
Value264388
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.26.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.26.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:Veklury srt:Europe100.0100.0

us-gaap:Product, country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value42134240530650763770398945164199405437964470413140693527413545424982
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax67.866.071.577.273.371.976.874.971.371.977.173.872.069.369.569.769.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax67.866.071.577.273.371.976.874.971.371.977.173.872.069.369.569.769.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Product, gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value792825656540573551440513512522398451466469553663665
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.712.88.88.211.19.97.59.29.09.96.98.18.39.29.310.29.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.712.88.88.211.19.97.59.29.09.96.98.18.39.29.310.29.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Product, srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value114712751366877724927840804104188281387310051005114911971399
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax18.419.918.413.314.116.714.314.318.316.714.015.617.819.819.318.419.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax18.419.918.413.314.116.714.314.318.316.714.015.617.819.819.318.419.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical

country:US


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value42334260532751003784400645354219407338184488415140833547415845635004
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax68.166.371.877.573.672.277.175.371.672.377.474.272.369.769.970.170.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax68.166.371.877.573.672.277.175.371.672.377.474.272.369.769.970.170.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherInternational


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value792827657540573567441514513525417470481484568678679
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.712.98.98.211.110.27.59.29.09.97.28.48.59.59.510.49.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.712.98.98.211.110.27.59.29.09.97.28.48.59.59.510.49.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

srt:Europe


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value119213361437937786975903871109993889097510841057122312711458
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.220.819.414.215.317.615.415.519.317.815.417.419.220.820.619.520.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.220.819.414.215.317.615.415.519.317.815.417.419.220.820.619.520.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenues

us-gaap:Revenues

us-gaap:Revenues


Revenues
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value62176423742165775143554858795604568552815795559656485088594965127141650573207500777677948506829582447594731460416534499831192782276725312588242624052282220021212137192619981937192720852032180116471530
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Revenues us-gaap:ProductOrService

gild:RoyaltyContractAndOther


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value93847681838878811141411088711211095
Percentage of Revenues1.31.31.51.51.41.61.41.52.02.51.91.71.91.71.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.31.51.51.41.61.41.52.02.51.91.71.91.71.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Product


Revenuesus-gaap:
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-31
Value649350675467551656075200
Percentage of Revenues98.798.598.598.498.698.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax98.798.598.598.498.698.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product100.0100.0100.0100.0100.0100.0

us-gaap:Revenues us-gaap:ProductOrService, us-gaap:StatementGeographical

gild:RoyaltyContractAndOther, country:US


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value212414171920192218201420232122
Percentage of Revenues0.30.40.30.30.30.40.30.40.30.40.20.40.40.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.40.30.30.30.40.30.40.30.40.20.40.40.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:RoyaltyContractAndOther, gild:OtherInternational


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1.00.00.0161.01.01.03.019191515151514
Percentage of Revenues0.00.00.00.30.00.00.00.10.30.30.30.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.30.00.00.00.10.30.30.30.30.30.20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther gild:OtherInternational100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:RoyaltyContractAndOther, srt:Europe


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value7160624863675856771027952747459
Percentage of Revenues1.00.91.20.91.11.21.01.11.31.81.41.01.21.10.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.20.91.11.21.01.11.31.81.41.01.21.10.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:RoyaltyContractAndOther srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Revenues us-gaap:StatementGeographical

country:US


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value532751003784400645354219407338184488415140833547415845635004
Percentage of Revenues71.877.573.672.277.175.371.672.377.474.272.369.769.970.170.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax71.877.573.672.277.175.371.672.377.474.272.369.769.970.170.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:OtherInternational


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value657540573567441514513525417470481484568678679
Percentage of Revenues8.98.211.110.27.59.29.09.97.28.48.59.59.510.49.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.98.211.110.27.59.29.09.97.28.48.59.59.510.49.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax gild:OtherInternational100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

srt:Europe


Revenuesus-gaap:
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1437937786975903871109993889097510841057122312711458
Percentage of Revenues19.414.215.317.615.415.519.317.815.417.419.220.820.619.520.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.414.215.317.615.415.519.317.815.417.419.220.820.619.520.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:SellingGeneralAndAdministrativeExpense


Selling
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value1351105517301106123910761204105210951030113194898099712528798978509928318906851066903812645876944613548513406404374365319332443346295304295280250248265
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax21.716.423.316.824.119.420.518.819.319.519.516.917.419.621.013.512.613.113.611.111.48.812.510.99.88.512.015.69.411.016.514.614.614.814.113.213.819.415.713.914.215.314.012.912.912.7

Assets

us-gaap:Assets

us-gaap:Assets


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value679846749268407608785593459741616275914663210628376367564305653556538170283646626026357701569775660949980477655183950637391673832134664288443120628077224962246822624222112123920963205011995017303126391269412987115929698
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value679846749268407608785593459741616275914663210628376367564305653556538170283646626026357701569775660949980477655183950637391673832134664288443120628077224962246822624222112123920963205011995017303126391269412987115929698
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value197031895218202174451802722067225252060422616219512138722861216722059120442248452267720441188871686815536133981853417414162871718015426135661609013387113691088311092101529309860380027313673861166046594658636367
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets29.028.126.628.732.236.936.634.835.834.933.635.633.231.529.138.437.635.433.129.831.128.035.834.441.644.844.547.051.647.750.548.449.045.743.841.039.036.738.948.447.645.850.665.6

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value-44.013653188508485
Percentage of StockholdersEquity-0.30.10.30.10.40.20.40.4
Percentage of Assets-0.10.00.10.10.10.10.10.1
Percentage of Assets us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value2639-33.01.01.0-3.0-22.0-52.0
Percentage of StockholdersEquity0.10.2-0.10.00.0-0.0-0.1-0.2
Percentage of Assets0.00.1-0.10.00.0-0.0-0.0-0.1
Percentage of Assets us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value2370468511710213080
Percentage of StockholdersEquity0.10.40.20.40.60.50.60.4
Percentage of Assets0.00.10.10.10.20.20.20.1
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value4118145328556847
Percentage of StockholdersEquity0.20.10.10.20.10.20.30.2
Percentage of Assets0.10.00.00.10.00.10.10.1
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.0

Assets Current

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value139251327815996309262464326950302962836133727340243583634918327283025831823353172859221424204452142518353192672476325910180932006217714125621549912970727369687072666361565880584458261391861476219685157084812
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets20.519.723.450.844.145.149.248.053.454.156.354.350.146.345.354.647.437.135.937.836.740.347.851.246.252.451.143.649.746.232.331.031.330.029.028.128.529.280.448.649.052.849.249.6

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


Cash
Period End2020-12-312019-12-312019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312008-12-312007-12-31
Value59971163111240169271794014569132347643758811508871210285822998096485631512851139657417106351002762098730640421122010220218631803155016251451988390990518359071022148293612721459968
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.818.917.826.928.222.720.211.710.817.814.517.814.417.313.013.224.827.618.927.828.921.528.022.89.48.99.78.48.57.47.97.357.17.27.114.17.80.00.00.013.10.00.0

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312016-12-31
Value489340655997128866746100511163194741124016927179401456975888229
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.26.08.821.212.116.818.916.017.826.928.222.710.814.4

Marketable Securities Current

us-gaap:MarketableSecuritiesCurrent

us-gaap:MarketableSecuritiesCurrent


Marketable
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1632160114111108912168107341272113382159431097712149138971268316355179221687912384383036662457226720041756174911946591011076864187858144820.0161347136411751190384
Percentage of MarketableSecuritiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.42.42.118.221.818.020.622.625.217.519.121.619.425.025.526.120.56.66.44.34.54.23.43.53.01.70.30.40.20.20.10.40.30.70.40.00.110.710.79.010.34.0

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent

us-gaap:AccountsReceivableNetCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value41493925489239133194390735823315339632833327346535413775385141224478403445145075575261635854610553314835463528503436323621001971189519451751176617022163195118671938180116211389
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.15.87.26.45.76.55.85.65.45.25.25.45.45.85.56.47.47.07.99.011.512.911.312.113.612.613.49.911.011.59.38.88.48.88.28.48.310.811.314.815.313.914.014.3

Inventory Net

us-gaap:InventoryNet

us-gaap:InventoryNet


Inventory
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1772177916831008105298692288288489881481685988580111441408147415871900186218801955198820391908138619092068214020551946193517991744161716031418138913371321130412031051
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.62.62.51.71.91.71.51.51.41.41.31.31.31.41.11.82.32.62.83.43.73.93.83.95.25.04.06.66.67.69.18.78.68.18.27.77.87.18.010.610.410.010.410.8

us-gaap:InventoryNet us-gaap:BalanceSheetLocation

us-gaap:AssetsTotal


Inventory
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value301420672630290231642726
Percentage of InventoryNet179.1224.2323.1362.3199.4139.4
Percentage of Assets4.43.44.14.15.65.3
Percentage of Assets us-gaap:AssetsTotal0.00.00.00.00.00.0

Prepaid Expense And Other Assets Current

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent


Prepaid
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312012-12-312011-12-31
Value1479190820132030148312721440130822641939160621712411160016611664161018011592142211522075151912091057186222
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.22.82.93.32.72.12.32.23.63.12.53.43.72.42.42.62.73.12.82.52.34.32.92.43.00.91.3

us-gaap:PrepaidExpenseAndOtherAssetsCurrent us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:Galapagos, gild:GalapagosSubscriptionAgreement


Prepaid
Period End2020-12-31
Value351
Percentage of PrepaidExpenseAndOtherAssetsCurrent17.4
Percentage of Assets0.5
Percentage of Assets gild:Galapagos gild:GalapagosSubscriptionAgreement0.0

gild:Galapagos, gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreement


Prepaid
Period End2020-09-30
Value505
Percentage of PrepaidExpenseAndOtherAssetsCurrent24.9
Percentage of Assets0.8
Percentage of Assets gild:Galapagos gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreement0.0

Land

us-gaap:Land

us-gaap:Land


Land
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value404404404396394393254195195149137
Percentage of Land100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.60.70.60.60.70.80.70.90.90.91.2

Machinery And Equipment Gross

us-gaap:MachineryAndEquipmentGross

us-gaap:MachineryAndEquipmentGross


Machinery
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value904805697533469377327250205199168
Percentage of MachineryAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.31.31.10.80.80.70.91.11.01.21.5

Noncurrent Assets

us-gaap:NoncurrentAssets us-gaap:StatementGeographical

us-gaap:NoncurrentAssets

country:US


Noncurrent
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value3800350032002600220018001300883
Percentage of NoncurrentAssets100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.65.75.03.73.93.53.83.9
Percentage of Assets country:US0.00.00.00.00.00.00.00.0

us-gaap:NonUs


Noncurrent
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value897791620520430334275
Percentage of NoncurrentAssets23.622.619.420.019.518.621.2
Percentage of Assets1.31.31.00.70.80.60.8
Percentage of Assets us-gaap:NonUs0.00.00.00.00.00.00.0

Property Plant And Equipment Gross

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:PropertyPlantAndEquipmentGross


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value663559245197428936832646204014721327983879
Percentage of PropertyPlantAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets9.79.68.26.16.55.15.96.56.35.77.6

Construction In Progress Gross

us-gaap:ConstructionInProgressGross

us-gaap:ConstructionInProgressGross


Construction
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value85672311946906415544111292166082
Percentage of ConstructionInProgressGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.31.21.91.01.11.11.20.61.00.40.7

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment


Accumulated
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Value166814221191994818763620501423358
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.42.31.91.41.41.51.82.22.02.1

Amortization Of Intangible Assets

us-gaap:AmortizationOfIntangibleAssets

us-gaap:AmortizationOfIntangibleAssets


Amortization
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-30
Value440395281282281281288299301300301212115151515171717
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value49964990496748104653456445024377424941164006379136593415329531003012292228652714259924312276214318991765167415091380130311661133113511251100856811782774761721703701699
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.37.47.37.98.37.67.37.46.76.66.35.95.65.24.74.85.05.15.04.85.25.14.44.24.84.64.85.24.44.65.25.05.05.15.24.14.03.94.56.05.75.46.07.2

Investments In Affiliates Subsidiaries Associates And Joint Ventures

us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures


Investments
Period End2021-06-302021-03-312020-12-312019-12-31
Value93695824
Percentage of InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures100.0100.0100.0100.0
Percentage of Assets0.10.10.10.0

Goodwill

us-gaap:Goodwill

us-gaap:Goodwill


Goodwill
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-07-192018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value8334833481084117411741174117411741174117411741170.041244159415911721172117211721172117211721172117211721172117211711171117111691188118811881060107810781078100410041004754532462
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets12.312.311.96.87.46.96.77.06.56.66.56.40.06.36.45.91.81.92.02.12.12.32.52.32.33.03.13.44.13.84.25.25.35.35.35.05.15.35.45.87.97.95.84.64.8

Indefinite Lived Intangible Assets Excluding Goodwill

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:InProcessResearchAndDevelopment


Indefinite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-31
Value161201717016890113012471247
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill100.0100.0100.0100.0100.0100.0
Percentage of Assets23.725.424.71.92.22.0
Percentage of Assets us-gaap:InProcessResearchAndDevelopment0.00.00.00.00.00.0

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill


Intangible
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
Value3434134781331261293913225135021378614864151521543815738163141649616803171008342855187618971938697139923102471045410660108671107311306115081170711900120341205612077117361173511751117671062
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets50.551.548.421.323.622.622.425.124.024.624.725.425.225.724.312.914.215.215.716.619.420.819.820.627.228.431.939.236.941.752.953.653.354.455.356.057.359.06.1

Finite Lived Intangible Assets Net

us-gaap:FiniteLivedIntangibleAssetsNet

us-gaap:FiniteLivedIntangibleAssetsNet


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312010-12-312009-12-31
Value182211761116236118091198312262125441282413109133961369413447137461405314350834285518761897191859395960598151002210228104351064110874109261112611325685707728750749764796863923
Percentage of FiniteLivedIntangibleAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets26.826.123.719.421.420.520.421.720.721.321.520.921.021.520.412.914.215.215.716.218.820.118.919.826.127.230.737.735.039.650.33.13.13.33.53.63.74.67.49.5

us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass

gild:AxicabtageneciloleucelDLBCL


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value5812591450955181526753535439552556125698578458705956604261280.0
Percentage of FiniteLivedIntangibleAssetsNet31.933.631.443.944.043.743.443.142.842.542.243.743.343.042.70.0
Percentage of Assets8.58.87.48.59.49.08.89.38.99.19.19.19.19.28.70.0
Percentage of Assets gild:AxicabtageneciloleucelDLBCL0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

gild:HepcludexForHDV


Finite
Period End2021-06-302021-03-31
Value816838
Percentage of FiniteLivedIntangibleAssetsNet4.54.8
Percentage of Assets1.21.2
Percentage of Assets gild:HepcludexForHDV0.00.0

gild:IntangibleAssetSofosbuvir


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value54185593576859436117629264676642681769917166734175157690786580408215839085649264
Percentage of FiniteLivedIntangibleAssetsNet29.731.835.550.351.051.351.651.852.052.252.354.654.754.754.896.496.195.895.594.4
Percentage of Assets8.08.38.49.810.910.510.511.210.811.111.311.411.511.811.212.413.614.515.017.9
Percentage of Assets gild:IntangibleAssetSofosbuvir0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

gild:Trodelvy


Finite
Period End2021-06-302020-12-31
Value53564537
Percentage of FiniteLivedIntangibleAssetsNet29.427.9
Percentage of Assets7.96.6
Percentage of Assets gild:Trodelvy0.00.0

gild:TrodelvyForMTNBC


Finite
Period End2021-03-312020-12-31
Value44424537
Percentage of FiniteLivedIntangibleAssetsNet25.227.9
Percentage of Assets6.66.6
Percentage of Assets gild:TrodelvyForMTNBC0.00.0

us-gaap:OtherIntangibleAssets


Finite
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value819824836685599617638657680707734198209227235155165175186226
Percentage of FiniteLivedIntangibleAssetsNet4.54.75.15.85.05.05.15.15.25.35.41.51.51.61.61.91.92.02.12.3
Percentage of Assets1.21.21.21.11.11.01.01.11.11.11.20.30.30.30.30.20.30.30.30.4
Percentage of Assets us-gaap:OtherIntangibleAssets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Lease Right Of Use Asset

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OperatingLeaseRightOfUseAsset


Operating
Period End2020-12-312019-12-312019-09-302019-06-302019-03-31
Value646668660504455
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0
Percentage of Assets0.91.11.10.80.7

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent

us-gaap:OtherAssetsNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value5552553057086012702070797438523229142921255527872609264227222611231923122214164714811294105685868258373126721220419513914314915917017116916013111912518185
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.28.28.39.912.611.812.18.84.64.64.04.34.04.03.94.03.84.03.92.93.02.72.01.71.71.52.10.90.70.70.90.60.60.70.70.80.80.80.91.00.91.01.60.9

Equity Securities Fv Ni

us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation

us-gaap:EquitySecuritiesFvNi

us-gaap:CashAndCashEquivalents


Equity
Period End2020-12-312019-12-312019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value43617069300737785305513870604714
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.411.54.86.08.38.010.86.7
Percentage of Assets us-gaap:CashAndCashEquivalents0.00.00.00.00.00.00.00.0

us-gaap:OtherNoncurrentAssets


Equity
Period End2020-12-312019-12-312019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value1756174166162142135128114
Percentage of EquitySecuritiesFvNi40.32.55.54.32.72.61.82.4
Percentage of Assets2.60.30.30.30.20.20.20.2
Percentage of Assets us-gaap:OtherNoncurrentAssets0.00.00.00.00.00.00.00.0

us-gaap:PrepaidExpensesAndOtherCurrentAssets


Equity
Period End2020-12-312019-12-312019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value85331911781105863829666637
Percentage of EquitySecuritiesFvNi19.64.539.229.216.316.19.413.5
Percentage of Assets1.20.51.91.81.41.31.00.9
Percentage of Assets us-gaap:PrepaidExpensesAndOtherCurrentAssets0.00.00.00.00.00.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:BalanceSheetLocation, us-gaap:FairValueByAssetClass

us-gaap:CashAndCashEquivalents, gild:OtherEquitySecurities


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
Value3383221643611143044197763706935995305
Percentage of EquitySecuritiesFvNi0.00.0100.00.00.00.0100.00.0100.0
Percentage of Assets5.03.36.418.87.913.011.56.18.3
Percentage of Assets us-gaap:CashAndCashEquivalents gild:OtherEquitySecurities0.00.00.00.00.00.00.00.00.0

us-gaap:OtherNoncurrentAssets, gild:OtherEquitySecurities


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
Value1792170817562194352234723651163142
Percentage of EquitySecuritiesFvNi0.00.040.30.00.00.051.60.02.7
Percentage of Assets2.62.52.63.66.35.85.90.30.2
Percentage of Assets us-gaap:OtherNoncurrentAssets gild:OtherEquitySecurities0.00.00.00.00.00.00.00.00.0

us-gaap:PrepaidExpensesAndOtherCurrentAssets, gild:OtherEquitySecurities


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
Value319797853986451239319292241
Percentage of EquitySecuritiesFvNi0.00.019.60.00.00.04.50.04.5
Percentage of Assets0.51.21.21.60.80.40.50.50.4
Percentage of Assets us-gaap:PrepaidExpensesAndOtherCurrentAssets gild:OtherEquitySecurities0.00.00.00.00.00.00.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

gild:DeferredCompensationPlan, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value248235218200183156171159156150124139131116
Percentage of EquitySecuritiesFvNi0.00.05.00.00.00.02.40.05.24.02.32.71.92.5
Percentage of Assets0.40.30.30.30.30.30.30.30.20.20.20.20.20.2
Percentage of Assets gild:DeferredCompensationPlan us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

gild:EquityinvestmentinGalapagos, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
Value11641302164823613283331634772082622
Percentage of EquitySecuritiesFvNi0.00.037.80.00.00.049.20.011.7
Percentage of Assets1.71.92.43.95.95.65.63.51.0
Percentage of Assets gild:EquityinvestmentinGalapagos us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.0

us-gaap:EquitySecurities, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value69996874361950723932228711721099881825663635
Percentage of EquitySecuritiesFvNi0.00.017.00.00.00.04.60.039.029.116.616.19.413.5
Percentage of Assets1.01.41.11.00.90.40.50.51.91.71.41.31.00.9
Percentage of Assets us-gaap:EquitySecurities us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value338322164361114304419776370693599300737785305513870604714
Percentage of EquitySecuritiesFvNi0.00.0100.00.00.00.0100.00.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.03.36.418.87.913.011.56.14.86.08.38.010.86.7
Percentage of Assets us-gaap:MoneyMarketFunds us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementBasis, us-gaap:FairValueByMeasurementFrequency

gild:DeferredCompensationPlan, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value248235218200183156171159156150124139131116
Percentage of EquitySecuritiesFvNi0.00.05.00.00.00.02.40.05.24.02.32.71.92.5
Percentage of Assets0.40.30.30.30.30.30.30.30.20.20.20.20.20.2
Percentage of Assets gild:DeferredCompensationPlan us-gaap:EstimateOfFairValueFairValueDisclosure us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

gild:EquityinvestmentinGalapagos, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
Value11641302164823613283331634772082622
Percentage of EquitySecuritiesFvNi0.00.037.80.00.00.049.20.011.7
Percentage of Assets1.71.92.43.95.95.65.63.51.0
Percentage of Assets gild:EquityinvestmentinGalapagos us-gaap:EstimateOfFairValueFairValueDisclosure us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.0

us-gaap:EquitySecurities, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value69996874361950723932229611881117881825663635
Percentage of EquitySecuritiesFvNi0.00.017.00.00.00.04.60.039.529.616.616.19.413.5
Percentage of Assets1.01.41.11.00.90.40.50.51.91.81.41.31.00.9
Percentage of Assets us-gaap:EquitySecurities us-gaap:EstimateOfFairValueFairValueDisclosure us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MoneyMarketFunds, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value338322164361114304419776370693599300737785305513870604714
Percentage of EquitySecuritiesFvNi0.00.0100.00.00.00.0100.00.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.03.36.418.87.913.011.56.14.86.08.38.010.86.7
Percentage of Assets us-gaap:MoneyMarketFunds us-gaap:EstimateOfFairValueFairValueDisclosure us-gaap:FairValueMeasurementsRecurring0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

gild:GalapagosNV


Equity
Period End2021-06-302021-03-312020-12-31
Value116413021648
Percentage of EquitySecuritiesFvNi0.00.037.8
Percentage of Assets1.71.92.4
Percentage of Assets gild:GalapagosNV0.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:BalanceSheetLocation

gild:GalapagosNV, us-gaap:OtherNoncurrentAssets


Equity
Period End2021-06-302021-03-312020-12-31
Value116410261297
Percentage of EquitySecuritiesFvNi0.00.029.7
Percentage of Assets1.71.51.9
Percentage of Assets gild:GalapagosNV us-gaap:OtherNoncurrentAssets0.00.00.0

gild:GalapagosNV, us-gaap:PrepaidExpensesAndOtherCurrentAssets


Equity
Period End2021-03-312020-12-31
Value276351
Percentage of EquitySecuritiesFvNi0.08.0
Percentage of Assets0.40.5
Percentage of Assets gild:GalapagosNV us-gaap:PrepaidExpensesAndOtherCurrentAssets0.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:ArcusBiosciencesInc, gild:ArcusCollaborationAgreementAndStockPurchaseAgreements


Equity
Period End2020-07-13
Value135
Percentage of EquitySecuritiesFvNi0.0
Percentage of Assets0.0
Percentage of Assets gild:ArcusBiosciencesInc gild:ArcusCollaborationAgreementAndStockPurchaseAgreements0.0

gild:ArcusBiosciencesInc, gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreement


Equity
Period End2020-09-30
Value135
Percentage of EquitySecuritiesFvNi0.0
Percentage of Assets0.2
Percentage of Assets gild:ArcusBiosciencesInc gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreement0.0

Accounts Payable Current

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value608570844527532590713632617577790580623711814696819944120610521122945117812391571101195511821162123412551350139013561327131913671339120610631102981803810
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.90.81.20.91.01.01.21.11.00.91.20.91.01.11.21.11.41.62.11.92.22.02.32.44.02.62.84.13.74.45.66.06.16.16.26.36.76.77.08.48.77.66.98.4

Accrued Income Taxes Current

us-gaap:AccruedIncomeTaxesCurrent

us-gaap:AccruedIncomeTaxesCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312016-09-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value4392155989439116452871901717667131863905165159356981054397152101037191317111440335.4382.4571.862167
Percentage of AccruedIncomeTaxesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.60.30.91.51.61.10.50.30.00.00.11.00.30.70.10.10.30.90.30.30.20.30.50.00.00.20.10.10.10.10.10.20.30.00.00.01.7

Accrued Liabilities Current

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value4055350743364141369628333074278527602348313923332607241433702482299126262790347828302925317227211873624593502495618566437384
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.05.26.36.86.64.75.04.74.43.74.93.64.03.74.83.85.04.64.96.15.76.16.15.45.43.03.02.93.94.94.43.84.0

Debt Current

us-gaap:DebtCurrent

us-gaap:DebtCurrent


Debt
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value22612259275714982999199924992498199924982748274729982497274717470.0700700174598333135244248314771572187126971457148894211691730197213511.5721.5877.3456536465.587
Percentage of DebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.33.34.02.55.43.34.14.23.24.04.34.34.63.83.92.70.01.21.43.71.90.70.91.21.45.15.06.712.06.56.64.25.58.39.66.80.00.00.15.05.60.1

Liabilities Current

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1021497051139795091056488799759956789619397106051011610912106701163595978492828292191107310444109109891936089257428576160546227591463254895493742904270480249864187251422242310276824641871
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets15.014.416.715.618.914.915.816.214.215.016.715.716.716.316.614.814.114.416.219.620.922.819.118.522.819.416.621.020.021.128.121.821.819.320.122.924.321.014.517.618.221.321.319.3

Long Term Debt Current

us-gaap:LongTermDebtCurrent

us-gaap:LongTermDebtCurrent


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
Value22612259275714982999199924992498199924982748274629982497274717470.00.00.070070095398333135244248314771572187126961457-1488.17-942.759-1169.4331730197213500.0
Percentage of LongTermDebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets3.33.34.02.55.43.34.14.23.24.04.34.34.63.83.92.70.00.00.01.21.42.01.90.70.91.21.45.15.06.712.06.5-6.6-4.2-5.58.39.66.80.0

Operating Lease Liability Current

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityCurrent


Operating
Period End2020-12-312019-12-31
Value10799
Percentage of OperatingLeaseLiabilityCurrent100.0100.0
Percentage of Assets0.20.2

Other Accrued Liabilities Current

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:OtherAccruedLiabilitiesCurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302011-12-31
Value2498227422872550228018082188211821521838202918181856171119181744182915891621208416571936184116231510144014521224144312221023816831819674647471
Percentage of OtherAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.73.43.34.24.13.03.63.63.42.93.22.82.82.62.72.73.02.82.83.73.34.13.63.23.93.84.24.24.64.44.63.63.73.73.23.12.7

Long Term Debt

us-gaap:LongTermDebt

us-gaap:LongTermDebt


Long
Period End2021-06-302021-03-312020-12-312018-09-302018-06-302017-12-312015-12-312015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302011-12-31
Value3017530166305002731629060335422217812363124049410950498036635731373377997822387717605
Percentage of LongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets44.444.744.642.544.547.742.832.335.832.630.534.929.532.532.436.038.741.844.0

us-gaap:LongTermDebt us-gaap:DebtInstrument, us-gaap:LongtermDebtType

gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-30
Value500500499499
Percentage of LongTermDebt1.71.71.60.0
Percentage of Assets0.70.70.70.8
Percentage of Assets gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021 us-gaap:SeniorNotes0.00.00.00.0

gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-30
Value498498498496
Percentage of LongTermDebt1.71.71.60.0
Percentage of Assets0.70.70.70.8
Percentage of Assets gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023 us-gaap:SeniorNotes0.00.00.00.0

gild:A075SeniorUnsecuredNotesDueInSeptember2023, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value1992
Percentage of LongTermDebt6.5
Percentage of Assets2.9
Percentage of Assets gild:A075SeniorUnsecuredNotesDueInSeptember2023 us-gaap:SeniorNotes0.0

gild:A075SeniorUnsecuredNotesDueSeptember2023, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-30
Value1994199319921992
Percentage of LongTermDebt6.66.66.50.0
Percentage of Assets2.93.02.93.3
Percentage of Assets gild:A075SeniorUnsecuredNotesDueSeptember2023 us-gaap:SeniorNotes0.00.00.00.0

gild:A120SeniorUnsecuredNotesDueOctober2027, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-30
Value746746745745
Percentage of LongTermDebt2.52.52.40.0
Percentage of Assets1.11.11.11.2
Percentage of Assets gild:A120SeniorUnsecuredNotesDueOctober2027 us-gaap:SeniorNotes0.00.00.00.0

gild:A195SeniorUnsecuredNotesDueMarch2022, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value500499499499499
Percentage of LongTermDebt1.71.71.60.00.0
Percentage of Assets0.70.70.70.80.8
Percentage of Assets gild:A195SeniorUnsecuredNotesDueMarch2022 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A250SeniorUnsecuredNotesDueSeptember2023, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value748748748747747
Percentage of LongTermDebt2.52.52.50.00.0
Percentage of Assets1.11.11.11.21.2
Percentage of Assets gild:A250SeniorUnsecuredNotesDueSeptember2023 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A280SeniorUnsecuredNotesDueOctober2050, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-30
Value1476147614761475
Percentage of LongTermDebt4.94.94.80.0
Percentage of Assets2.22.22.22.4
Percentage of Assets gild:A280SeniorUnsecuredNotesDueOctober2050 us-gaap:SeniorNotes0.00.00.00.0

gild:A295SeniorUnsecuredNotesDueMarch2027, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value12461246124612461245
Percentage of LongTermDebt4.14.14.10.00.0
Percentage of Assets1.81.81.82.02.0
Percentage of Assets gild:A295SeniorUnsecuredNotesDueMarch2027 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A325SeniorUnsecuredNotesDueSeptember2022, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value999999998998998
Percentage of LongTermDebt3.33.33.30.00.0
Percentage of Assets1.51.51.51.61.6
Percentage of Assets gild:A325SeniorUnsecuredNotesDueSeptember2022 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A350SeniorUnsecuredNotesDueFebruary2025, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value17471747174617461746
Percentage of LongTermDebt5.85.85.70.00.0
Percentage of Assets2.62.62.62.92.8
Percentage of Assets gild:A350SeniorUnsecuredNotesDueFebruary2025 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A365SeniorUnsecuredNotesDueMarch2026, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value27382737273727362734
Percentage of LongTermDebt9.19.19.00.00.0
Percentage of Assets4.04.14.04.54.4
Percentage of Assets gild:A365SeniorUnsecuredNotesDueMarch2026 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A370SeniorUnsecuredNotesDueApril2024, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value17471746174617461745
Percentage of LongTermDebt5.85.85.70.00.0
Percentage of Assets2.62.62.62.92.8
Percentage of Assets gild:A370SeniorUnsecuredNotesDueApril2024 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A400SeniorUnsecuredNotesDueSeptember2036, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value742742741741741
Percentage of LongTermDebt2.52.52.40.00.0
Percentage of Assets1.11.11.11.21.2
Percentage of Assets gild:A400SeniorUnsecuredNotesDueSeptember2036 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A415SeniorUnsecuredNotesDueMarch2047, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value17271726172617261725
Percentage of LongTermDebt5.75.75.70.00.0
Percentage of Assets2.52.62.52.82.8
Percentage of Assets gild:A415SeniorUnsecuredNotesDueMarch2047 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A440SeniorUnsecuredNotesDueDecember2021, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value12491249124912491248
Percentage of LongTermDebt4.14.14.10.00.0
Percentage of Assets1.81.91.82.12.0
Percentage of Assets gild:A440SeniorUnsecuredNotesDueDecember2021 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A450SeniorUnsecuredNotesDueApril2021, us-gaap:SeniorNotes


Long
Period End2020-12-312020-09-302019-12-31
Value1000999998
Percentage of LongTermDebt3.30.00.0
Percentage of Assets1.51.61.6
Percentage of Assets gild:A450SeniorUnsecuredNotesDueApril2021 us-gaap:SeniorNotes0.00.00.0

gild:A450SeniorUnsecuredNotesDueFebruary2045, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value17321732173217321731
Percentage of LongTermDebt5.75.75.70.00.0
Percentage of Assets2.52.62.52.82.8
Percentage of Assets gild:A450SeniorUnsecuredNotesDueFebruary2045 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A460SeniorUnsecuredNotesDueSeptember2035, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value992992991991991
Percentage of LongTermDebt3.33.33.20.00.0
Percentage of Assets1.51.51.41.61.6
Percentage of Assets gild:A460SeniorUnsecuredNotesDueSeptember2035 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A475SeniorUnsecuredNotesDueMarch2046, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value22192219221922182217
Percentage of LongTermDebt7.47.47.30.00.0
Percentage of Assets3.33.33.23.63.6
Percentage of Assets gild:A475SeniorUnsecuredNotesDueMarch2046 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A480SeniorUnsecuredNotesDueApril2044, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value17351735173517351734
Percentage of LongTermDebt5.75.85.70.00.0
Percentage of Assets2.62.62.52.82.8
Percentage of Assets gild:A480SeniorUnsecuredNotesDueApril2044 us-gaap:SeniorNotes0.00.00.00.00.0

gild:A565SeniorUnsecuredNotesDueDecember2041, us-gaap:SeniorNotes


Long
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value996996996996995
Percentage of LongTermDebt3.33.33.30.00.0
Percentage of Assets1.51.51.51.61.6
Percentage of Assets gild:A565SeniorUnsecuredNotesDueDecember2041 us-gaap:SeniorNotes0.00.00.00.00.0

gild:SeniorUnsecuredNotesDueApril2021, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value1000998
Percentage of LongTermDebt3.30.0
Percentage of Assets1.51.6
Percentage of Assets gild:SeniorUnsecuredNotesDueApril2021 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueDecember2021, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value12491248
Percentage of LongTermDebt4.10.0
Percentage of Assets1.82.0
Percentage of Assets gild:SeniorUnsecuredNotesDueDecember2021 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueDecember2041, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value996995
Percentage of LongTermDebt3.30.0
Percentage of Assets1.51.6
Percentage of Assets gild:SeniorUnsecuredNotesDueDecember2041 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinApril2024, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value17461745
Percentage of LongTermDebt5.70.0
Percentage of Assets2.62.8
Percentage of Assets gild:SeniorUnsecuredNotesDueinApril2024 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinApril2044, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value17351734
Percentage of LongTermDebt5.70.0
Percentage of Assets2.52.8
Percentage of Assets gild:SeniorUnsecuredNotesDueinApril2044 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinFebruary2045, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value17321731
Percentage of LongTermDebt5.70.0
Percentage of Assets2.52.8
Percentage of Assets gild:SeniorUnsecuredNotesDueinFebruary2045 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinMarch2026, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value27372734
Percentage of LongTermDebt9.00.0
Percentage of Assets4.04.4
Percentage of Assets gild:SeniorUnsecuredNotesDueinMarch2026 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinMarch2027, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value12461245
Percentage of LongTermDebt4.10.0
Percentage of Assets1.82.0
Percentage of Assets gild:SeniorUnsecuredNotesDueinMarch2027 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinMarch2046, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value22192217
Percentage of LongTermDebt7.30.0
Percentage of Assets3.23.6
Percentage of Assets gild:SeniorUnsecuredNotesDueinMarch2046 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinMarch2047, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value17261725
Percentage of LongTermDebt5.70.0
Percentage of Assets2.52.8
Percentage of Assets gild:SeniorUnsecuredNotesDueinMarch2047 us-gaap:SeniorNotes0.00.0

gild:SeniorUnsecuredNotesDueinSeptember2023, us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value748747
Percentage of LongTermDebt2.50.0
Percentage of Assets1.11.2
Percentage of Assets gild:SeniorUnsecuredNotesDueinSeptember2023 us-gaap:SeniorNotes0.00.0

gild:VariableTermLoanNoteDueOctober2023, us-gaap:MediumTermNotes


Long
Period End2021-06-302021-03-312020-12-31
Value748748998
Percentage of LongTermDebt2.52.53.3
Percentage of Assets1.11.11.5
Percentage of Assets gild:VariableTermLoanNoteDueOctober2023 us-gaap:MediumTermNotes0.00.00.0

gild:VariableTermLoanNoteDueOctober2023, us-gaap:SeniorNotes


Long
Period End2020-12-31
Value998
Percentage of LongTermDebt3.3
Percentage of Assets1.5
Percentage of Assets gild:VariableTermLoanNoteDueOctober2023 us-gaap:SeniorNotes0.0

us-gaap:LongTermDebt us-gaap:LongtermDebtType

gild:SeniorNotesAndMediumTermNotes


Long
Period End2021-06-302021-03-312020-12-31
Value290572905230295
Percentage of LongTermDebt96.396.399.3
Percentage of Assets42.743.044.3
Percentage of Assets gild:SeniorNotesAndMediumTermNotes0.00.00.0

us-gaap:NotesPayableOtherPayables


Long
Period End2021-06-302021-03-312020-12-31
Value111811141107
Percentage of LongTermDebt3.73.73.6
Percentage of Assets1.61.71.6
Percentage of Assets us-gaap:NotesPayableOtherPayables0.00.00.0

us-gaap:SeniorNotes


Long
Period End2020-12-312019-12-31
Value3029524593
Percentage of LongTermDebt99.30.0
Percentage of Assets44.339.9
Percentage of Assets us-gaap:SeniorNotes0.00.0

Long Term Debt Noncurrent

us-gaap:LongTermDebtNoncurrent

us-gaap:LongTermDebtNoncurrent


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
Value279142790728645277922110322098220942209024084240802457424570260622655730795275152629626321263462637121427210772119521894119221192111921793379327932393858565849705470547040712680777605
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets41.141.341.945.737.737.035.937.338.138.338.638.239.940.643.842.643.645.646.246.642.944.140.943.230.431.134.427.525.428.317.526.125.931.833.233.634.840.544.0

Deferred Income Tax Liabilities Net

us-gaap:DeferredIncomeTaxLiabilitiesNet

us-gaap:DeferredIncomeTaxLiabilitiesNet


Deferred
Period End2021-06-302021-03-312020-12-31
Value437444643914
Percentage of DeferredIncomeTaxLiabilitiesNet100.0100.0100.0
Percentage of Assets6.46.65.7

Minority Interest

us-gaap:MinorityInterest

us-gaap:MinorityInterest


Minority
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value7.01219261151121251321351401471466260594094144764764925796215795303474083932973383143753082512402411468150128116164229258138
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.20.20.20.20.20.20.20.20.10.10.10.60.70.80.80.91.21.31.11.00.91.11.11.01.11.11.71.41.11.11.10.70.40.30.70.91.31.82.21.4

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OtherLiabilitiesNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value117614305128108610189901009901157714601040594646671558259442333296184467374395378760619535482174174156261224213228221155153147138156492735
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.72.17.51.81.81.71.61.52.52.31.60.91.01.00.80.40.70.60.50.30.90.80.80.71.91.61.51.70.60.60.71.21.01.01.11.10.80.80.91.11.20.40.20.4

Operating Lease Liability Noncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent


Operating
Period End2020-12-312019-12-31
Value608626
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0
Percentage of Assets0.91.0

Lessee Operating Lease Liability Payments Due Year Two

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo


Lessee
Period End2020-12-31
Value122
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearTwo100.0
Percentage of Assets0.2

Lessee Operating Lease Liability Payments Due Year Three

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree


Lessee
Period End2020-12-31
Value112
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearThree100.0
Percentage of Assets0.2

Lessee Operating Lease Liability Payments Due Year Four

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour


Lessee
Period End2020-12-31
Value97
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFour100.0
Percentage of Assets0.1

Lessee Operating Lease Liability Payments Due Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive


Lessee
Period End2020-12-31
Value70
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFive100.0
Percentage of Assets0.1

Lessee Operating Lease Liability Payments Due After Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive


Lessee
Period End2020-12-31
Value300
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive100.0
Percentage of Assets0.4

Operating Lease Liability

us-gaap:OperatingLeaseLiability

us-gaap:OperatingLeaseLiability


Operating
Period End2020-12-312019-12-312019-09-302019-06-302019-03-31
Value715725712554504
Percentage of OperatingLeaseLiability100.0100.0100.0100.0100.0
Percentage of Assets1.01.21.20.90.8

Lessee Operating Lease Liability Payments Due

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue


Lessee
Period End2020-12-31
Value828
Percentage of LesseeOperatingLeaseLiabilityPaymentsDue100.0
Percentage of Assets1.2

Lessee Operating Lease Liability Undiscounted Excess Amount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount


Lessee
Period End2020-12-31
Value113
Percentage of LesseeOperatingLeaseLiabilityUndiscountedExcessAmount100.0
Percentage of Assets0.2

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value197031895218202174451802722067225252060422616219512138722861216722059120442248452267720441188871686815536133981853417414162871718015426135661609013387113691088311092101529309860380027313673861166046594658636367
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets29.028.126.628.732.236.936.634.835.834.933.635.633.231.529.138.437.635.433.129.831.128.035.834.441.644.844.547.051.647.750.548.449.045.743.841.039.036.738.948.447.645.850.665.6

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value-44.013653188508485
Percentage of StockholdersEquity-0.30.10.30.10.40.20.40.4
Percentage of Assets-0.10.00.10.10.10.10.10.1
Percentage of Assets us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value2639-33.01.01.0-3.0-22.0-52.0
Percentage of StockholdersEquity0.10.2-0.10.00.0-0.0-0.1-0.2
Percentage of Assets0.00.1-0.10.00.0-0.0-0.0-0.1
Percentage of Assets us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value2370468511710213080
Percentage of StockholdersEquity0.10.40.20.40.60.50.60.4
Percentage of Assets0.00.10.10.10.20.20.20.1
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment


Stockholders
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value4118145328556847
Percentage of StockholdersEquity0.20.10.10.20.10.20.30.2
Percentage of Assets0.10.00.00.10.00.10.10.1
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.0

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-312007-12-31
Value19710189641822117471181422217922650207362275122091215342300721734206512050125254230912091719363173601611514019191131794416634175881581913863164291370211744111921134310392955087508083736468676233621161756121650544653752
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets29.028.126.628.732.437.136.835.136.035.233.835.833.331.629.239.138.336.334.030.732.229.336.935.442.545.945.648.152.648.852.249.850.146.845.041.739.436.939.749.348.947.552.867.10.00.0

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent


Stockholders
Period End2021-06-302021-03-312020-12-312020-06-302020-03-312019-12-31
Value-16.0-23.0-113.0136531
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-0.1-0.1-0.60.10.30.1
Percentage of Assets-0.0-0.0-0.20.00.10.1
Percentage of Assets us-gaap:AccumulatedGainLossNetCashFlowHedgeParent0.00.00.00.00.00.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges


Stockholders
Period End2020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312014-12-31
Value-113.031885084853836-127.0-114.0-120.0-69.033162149343
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-0.60.10.40.20.40.40.20.2-0.6-0.6-0.5-0.30.20.80.82.2
Percentage of Assets-0.20.10.10.10.10.10.10.1-0.2-0.2-0.2-0.10.10.30.31.0
Percentage of Assets us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss


Stockholders
Period End2021-06-302020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312014-12-31
Value-1.02.039-33.01.01.0-3.0-22.0-52.0-70.0-101.0-135.0194288104171-16.0-16.012
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-0.00.00.2-0.10.00.0-0.0-0.1-0.2-0.3-0.5-0.70.91.10.50.8-0.1-0.10.1
Percentage of Assets-0.00.00.1-0.10.00.0-0.0-0.0-0.1-0.1-0.2-0.20.30.40.20.3-0.0-0.00.0
Percentage of Assets us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-312013-12-31
Value3938-60.02370468511710213080362.0-170.0165249120260278-108.0-46.0-164.088167247301-124.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.20.2-0.30.10.40.20.40.60.40.60.40.20.0-0.80.81.00.51.21.4-0.6-0.3-1.20.50.91.51.9-1.1
Percentage of Assets0.10.1-0.10.00.10.10.10.20.20.20.10.10.0-0.30.20.40.20.50.5-0.2-0.1-0.30.20.30.60.9-0.6
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment


Stockholders
Period End2021-06-302021-03-312020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312014-12-31
Value5661511814532855684768679285818556132-45.0-54.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.30.30.30.10.10.20.10.20.30.20.30.30.40.40.30.40.30.7-0.2-0.3
Percentage of Assets0.10.10.10.00.00.10.00.10.10.10.10.10.10.10.10.10.10.2-0.1-0.2
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-312013-12-31
Value4271409238803712351133113051287026842494228221181844156412649067336164543216325164442850.023915386
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest21.721.621.321.219.414.913.513.811.811.310.69.28.57.66.23.63.22.92.31.83.93.72.31.60.015.145.9
Percentage of Assets6.36.15.76.16.35.55.04.94.24.03.63.32.82.41.81.41.21.10.80.61.31.10.90.60.06.923.9
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-312013-12-31
Value1.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.01.02.02.02.0
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-312013-12-31
Value7.0121926115112125132135140147146626059409414476476492579621579530347393375
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.00.10.10.10.60.50.60.60.60.60.70.60.30.30.31.61.82.32.52.83.64.43.03.02.12.53.2
Percentage of Assets0.00.00.00.00.20.20.20.20.20.20.20.20.10.10.10.60.70.80.80.91.21.31.11.00.91.11.7
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-312013-12-31
Value15392148211438113709144451870919388176161982919326190242070619825191961901223689218231956418154166541494913045180011696116038127326106
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest78.178.278.978.579.684.485.685.087.287.588.390.091.293.092.793.894.593.593.895.992.893.194.294.596.480.552.0
Percentage of Assets22.622.021.022.525.831.331.529.831.430.829.932.230.329.427.136.636.233.931.929.429.927.334.733.540.936.727.1
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.01000000.02000000.01000000.02000000.01514000.01526000.01538000.01534000.0763000.0765000.0760000.0760000.0758000.0756000.0758000.0753000.0757000.0777000.0791000.0802000.0900000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Additional Paid In Capital

us-gaap:AdditionalPaidInCapital

us-gaap:AdditionalPaidInCapital


Additional
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value4271409238803712351133113051287026842494228221181844156412649067336164543216325164442850.02724239121435930574653865189599558295649543552135100490348094783472646484376
Percentage of AdditionalPaidInCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.36.15.76.16.35.55.04.94.24.03.63.32.82.41.81.41.21.10.80.61.31.10.90.60.07.16.97.419.020.523.923.126.526.226.625.925.425.628.338.137.736.440.145.1

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


Retained
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1539214821143811370914445187091938817616198291932619024207061982519196190122368921823195641815416654149491304518001169611603813916127321124710199773461055735506543013704313926632178177613211395132011831995
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets22.622.021.022.525.831.331.529.831.430.829.932.230.329.427.136.636.233.931.929.429.927.334.733.540.936.336.739.032.727.527.125.522.419.417.415.013.010.910.310.511.010.210.220.6

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax


Accumulated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value3938-60.02370468511710213080362.0-170.0165249120260278-108.0-46.0-164.088167247539301173-41.46-95.769-124.446-42.073020-45.615281243358-15.541-133.279-101.18230-5.758
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.1-0.10.00.10.10.10.20.20.20.10.10.0-0.30.20.40.20.50.5-0.2-0.1-0.30.20.30.61.40.90.6-0.1-0.3-0.6-0.20.10.1-0.20.10.60.20.3-0.1-1.0-0.80.3-0.1

Minority Interest

us-gaap:MinorityInterest

us-gaap:MinorityInterest


Minority
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value7.01219261151121251321351401471466260594094144764764925796215795303474083932973383143753082512402411468150128116164229258138
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.20.20.20.20.20.20.20.20.10.10.10.60.70.80.80.91.21.31.11.00.91.11.11.01.11.11.71.41.11.11.10.70.40.30.70.91.31.82.21.4

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value168140160173168141159160175144175190253224313114102891039595889997
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value168140160173168141159160175144175190253224313114102891039595889997
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value2316261019162250256614362580289922211444234522121573227027532694352629253486433049403913487440965658570130204044418515687267539536727057451290452978897943820724739699670
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax37.340.625.834.249.925.943.951.739.127.340.539.527.944.646.341.449.445.047.657.763.550.257.349.468.675.141.366.964.031.423.327.134.426.527.330.753.719.844.542.344.142.636.338.236.332.1

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-577.0-2042.0-8977.0-271.0-5023.0-344.0431-2095.0-6042.0-111.02735202552414354-10016.0-2114.0-4246.0307-2675.0-3917.0-3284.0-2109.0-2438.0-4186.0-3552.0-2299.0-404.759-770.053-487.248-160.94216-8.032-55.477-407.25650-518.044-634.964-10743.1164440-80.32-469.79-300.381-407.816-1394.129932-1068.778
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.3-31.8-121.0-4.1-97.7-6.27.3-37.4-106.3-2.147.236.292.885.6-168.4-32.5-59.54.7-36.5-52.2-42.2-27.1-28.7-50.5-43.1-30.3-5.5-12.7-7.5-3.26.9-0.3-2.0-16.11.9-21.3-26.4-470.7201.8-3.8-22.0-15.6-20.4-71.948.4-51.2

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-931.0-2477.01314124-874.0-2611.0-896.0-2515.0-1857.0-2366.0-1670.0-2901.0-1152.0-6595.033472170-880.0-1244.0-2295.02860-1516.0-8396.0-3544.06644-5341.0-2722.01233-5771.421-1371.5912884-845.059-942.233-557.648-199.001-509.851-307.514-474.87918553526-876.199-1371.962485-459.656270-1165.53616
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-15.0-38.61.862.7-17.0-47.1-15.2-44.9-32.7-44.8-28.8-51.8-20.4-129.656.333.3-12.3-19.1-31.438.1-19.5-107.7-41.780.1-64.8-35.816.9-95.5-21.057.7-27.1-33.9-20.2-7.9-19.7-12.7-19.781.3160.3-41.3-64.225.2-23.014.0-60.50.8

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value828-1932.0-6889.06140-3305.0-1580.02157-1766.0-5687.0-1013.03371
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.3-30.1-92.893.4-64.3-28.536.7-31.5-100.0-19.258.2

Deferred Income Tax Expense Benefit

us-gaap:DeferredIncomeTaxExpenseBenefit

us-gaap:DeferredIncomeTaxExpenseBenefit


Deferred
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312011-06-302011-03-312010-06-302010-03-31
Value-68.071-121.05356-824.04.02412-37.035-11.0805821-131.0151920-1.16431
Percentage of DeferredIncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Accounts Payable

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsPayable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value31-253.0214-21.0-4.0-109.0812435-201.0178-24.0-101.0-92.085-116.0-137.0-262.0162-48.0172-239.0-62.0-332.056258-214.40115-69.828-20.117-120.804-41.73430-28.973-84.156122107171-37.843119176-146.145-120.57120141
Percentage of IncreaseDecreaseInAccountsPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Accounts Receivable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInAccountsReceivable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value281-975.0837702-744.0376251-101.0100-32.0-113.0-90.0-176.0-101.0-281.0-355.0419-537.0-422.0-580.0-381.0191-213.08004623481751-505.42521411178845-50.515231-37.15519-376.698196154-0.573114107-3.20610978163
Percentage of IncreaseDecreaseInAccountsReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Inventories

us-gaap:IncreaseDecreaseInInventories

us-gaap:IncreaseDecreaseInInventories


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value25691472637-15.06023-3.0151191572014174659.05.0214177831419625264370-42.172-121.691-63.748841261514357125111862664221797-67.073-89.28142174
Percentage of IncreaseDecreaseInInventories100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value2316261019162250256614362580289922211444234522121573227027532694352629253486433049403913487440965658570130204044418515687267539536727057451290452978897943820724739699670
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax37.340.625.834.249.925.943.951.739.127.340.539.527.944.646.341.449.445.047.657.763.550.257.349.468.675.141.366.964.031.423.327.134.426.527.330.753.719.844.542.344.142.636.338.236.332.1

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value152217291551360-3339.015512696-1165.0188019753.0209718171538-3865.0271830732702310833303497356646834600449243333487273136552227791788772722762675706437665741746651629704712854802673571589
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.526.920.95.5-64.928.045.9-20.833.137.40.137.532.230.2-65.041.743.041.542.544.445.045.855.155.554.557.147.745.255.944.625.428.327.928.529.527.829.419.230.234.934.933.831.536.436.941.039.537.434.738.5

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
Value151717221544353-3346.015382689-1168.0187519683.0209918191539-3836.0271230692699309933253497356746854592449743323462272436502222786785767717758671711441661737742647626702709852799670569586
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.426.820.85.4-65.127.745.7-20.833.037.30.137.532.230.2-64.541.643.041.542.344.345.045.855.155.454.557.047.345.155.944.525.228.227.728.329.327.729.619.430.134.834.733.631.336.236.840.939.337.234.638.3

us-gaap:ProfitLoss us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value-5.0-7.0-7.0-7.0-7.0-13.0-7.0-3.0-5.0-7.00.02.02.01.029-6.0-4.0-3.0-9.0-5.00.01.02.0-8.0
Percentage of ProfitLoss-0.3-0.4-0.5-2.00.2-0.8-0.30.3-0.3-0.40.00.10.10.1-0.8-0.2-0.1-0.1-0.3-0.20.00.00.0-0.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.1-0.1-0.1-0.1-0.2-0.1-0.1-0.1-0.10.00.00.00.00.5-0.1-0.1-0.0-0.1-0.10.00.00.0-0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value152217291551360-3339.015512696-1165.0188019753.0209718171538-3865.0271830732702310833303497356646834600
Percentage of ProfitLoss100.3100.4100.5102.099.8100.8100.399.7100.3100.4100.099.999.999.9100.8100.2100.1100.1100.3100.2100.0100.0100.0100.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.526.920.95.5-64.928.045.9-20.833.137.40.137.532.230.2-65.041.743.041.542.544.445.045.855.155.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Share Based Compensation

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value16613916117316814115716217414317519825222033411310289102959588979796929599838271625561575448484646504953514846
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-577.0-2042.0-8977.0-271.0-5023.0-344.0431-2095.0-6042.0-111.02735202552414354-10016.0-2114.0-4246.0307-2675.0-3917.0-3284.0-2109.0-2438.0-4186.0-3552.0-2299.0-404.759-770.053-487.248-160.94216-8.032-55.477-407.25650-518.044-634.964-10743.1164440-80.32-469.79-300.381-407.816-1394.129932-1068.778
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.3-31.8-121.0-4.1-97.7-6.27.3-37.4-106.3-2.147.236.292.885.6-168.4-32.5-59.54.7-36.5-52.2-42.2-27.1-28.7-50.5-43.1-30.3-5.5-12.7-7.5-3.26.9-0.3-2.0-16.11.9-21.3-26.4-470.7201.8-3.8-22.0-15.6-20.4-71.948.4-51.2

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value119165181155143171203200185237248167297212129123118198204177
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-931.0-2477.01314124-874.0-2611.0-896.0-2515.0-1857.0-2366.0-1670.0-2901.0-1152.0-6595.033472170-880.0-1244.0-2295.02860-1516.0-8396.0-3544.06644-5341.0-2722.01233-5771.421-1371.5912884-845.059-942.233-557.648-199.001-509.851-307.514-474.87918553526-876.199-1371.962485-459.656270-1165.53616
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-15.0-38.61.862.7-17.0-47.1-15.2-44.9-32.7-44.8-28.8-51.8-20.4-129.656.333.3-12.3-19.1-31.438.1-19.5-107.7-41.780.1-64.8-35.816.9-95.5-21.057.7-27.1-33.9-20.2-7.9-19.7-12.7-19.781.3160.3-41.3-64.225.2-23.014.0-60.50.8

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt

us-gaap:RepaymentsOfLongTermDebt


Repayments
Period End2021-06-302021-03-31
Value0.01250
Percentage of RepaymentsOfLongTermDebt0.0100.0

us-gaap:RepaymentsOfLongTermDebt us-gaap:DebtInstrument, us-gaap:SubsequentEventType

gild:A440SeniorUnsecuredNotesDueDecember2021, us-gaap:SubsequentEvent


Repayments
Period End2021-08-06
Value1250
Percentage of RepaymentsOfLongTermDebt0.0

us-gaap:RepaymentsOfLongTermDebt us-gaap:StatementScenario, us-gaap:DebtInstrument

srt:ScenarioForecast, gild:A440SeniorUnsecuredNotesDueDecember2021


Repayments
Period End2021-09-30
Value1250
Percentage of RepaymentsOfLongTermDebt0.0

Payments Of Dividends

us-gaap:PaymentsOfDividends

us-gaap:PaymentsOfDividends


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
Value8949178588618568748018048008177367427407536826826806876196236265876146276330.00.00.0
Percentage of PaymentsOfDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

Dividends

us-gaap:Dividends

us-gaap:Dividends


Dividends
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-30
Value903906865866866867808807810814741746747752687685685685622625631587620631639
Percentage of Dividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Dividends us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Dividendsus-gaap:
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value903906865866866867808807810814741746747752687685685685622625631587620631
Percentage of Dividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments For Repurchase Of Common Stock

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:PaymentsForRepurchaseOfCommonStock


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value433090.0201541328105222588834962449450103910615313056510001000100180003051305090030012000170012004504001000.0822002052412022688372454861515521691162
Percentage of PaymentsForRepurchaseOfCommonStock100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Effective Income Tax Rate Continuing Operations

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:EffectiveIncomeTaxRateContinuingOperations


Effective
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312016-09-302016-06-302015-12-312015-09-302015-06-302014-12-312014-09-302014-06-302013-12-312013-09-302013-06-302012-12-312012-09-302012-06-302011-09-30
Value16.523.9998.157.2-0.1250.232-0.2190.2220.2220.1630.1050.2120.1280.2430.4010.2610.254-0.0010.2220.205-0.0090.1610.184-0.0030.1920.1520.0070.2730.286-0.0120.2940.2720.244
Percentage of EffectiveIncomeTaxRateContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:EmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value161923302327395472
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value69.461.3553.843.9337.6928.5622.6319.3417.21
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Liabilities

us-gaap:DeferredTaxLiabilities

us-gaap:DeferredTaxLiabilities


Deferred
Period End2020-12-312018-12-312017-12-312011-12-312010-12-312009-12-31
Value2612538247360358417
Percentage of DeferredTaxLiabilities100.0100.0100.0100.0100.0100.0

Deferred Tax Assets Net

us-gaap:DeferredTaxAssetsNet

us-gaap:DeferredTaxAssetsNet


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Value3960313812091139139014621063811729701775801
Percentage of DeferredTaxAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Unrecognized Tax Benefits

us-gaap:UnrecognizedTaxBenefits

us-gaap:UnrecognizedTaxBenefits


Unrecognized
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value161420311595218118521350661236156146126106121115
Percentage of UnrecognizedTaxBenefits100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Assets Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance

us-gaap:DeferredTaxAssetsValuationAllowance


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Value3982173311621266.09.08.9319.4889.209131.078
Percentage of DeferredTaxAssetsValuationAllowance100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

gild:CashPaymentsMadeRelatedToEquityInvestments us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

gild:CashPaymentsMadeRelatedToEquityInvestments

gild:JounceTherapeuticsInc, us-gaap:SubsequentEvent, gild:LicenseRegistrationRightsAndStockPurchaseAgreement


Cash
Period End2020-10-31
Value56
Percentage of CashPaymentsMadeRelatedToEquityInvestments100.0

gild:CashPaymentsMadeRelatedToEquityInvestments us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:JounceTherapeuticsInc, gild:LicenseRegistrationRightsAndStockPurchaseAgreement


Cash
Period End2020-10-31
Value56
Percentage of CashPaymentsMadeRelatedToEquityInvestments100.0

gild:TangoTherapeuticsInc, gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreement


Cash
Period End2020-08-17
Value20
Percentage of CashPaymentsMadeRelatedToEquityInvestments0.0

gild:CashPaymentsMadeRelatedToEquityInvestments us-gaap:TypeOfArrangement

gild:OtherCollaborationArrangements


Cash
Period End2021-03-312020-12-312020-09-302020-03-312019-12-312019-09-302019-06-30
Value5911368.0-1.01548
Percentage of CashPaymentsMadeRelatedToEquityInvestments0.00.00.00.00.00.00.0

gild:CollaborationArrangementNetProductSalesThreshold us-gaap:ProductOrService, us-gaap:TypeOfArrangement

gild:CollaborationArrangementNetProductSalesThreshold

gild:InjectableFormulationProduct, gild:MerckSharpDohmeCorpLicenseAndCollaborationAgreement


Collaboration
Period End2021-03-13
Value3500
Percentage of CollaborationArrangementNetProductSalesThreshold100.0

gild:OralFormulationProduct, gild:MerckSharpDohmeCorpLicenseAndCollaborationAgreement


Collaboration
Period End2021-03-13
Value2000
Percentage of CollaborationArrangementNetProductSalesThreshold57.1

gild:CollaborationArrangementPercentOfGlobalDevelopmentAndCommercializationCosts dei:LegalEntity, us-gaap:TypeOfArrangement

gild:CollaborationArrangementPercentOfGlobalDevelopmentAndCommercializationCosts

gild:Merck, gild:MerckSharpDohmeCorpLicenseAndCollaborationAgreement


Collaboration
Period End2021-03-13
Value40.0
Percentage of CollaborationArrangementPercentOfGlobalDevelopmentAndCommercializationCosts100.0

gild:CollaborationArrangementPercentOfGlobalDevelopmentAndCommercializationCosts us-gaap:TypeOfArrangement

gild:MerckSharpDohmeCorpLicenseAndCollaborationAgreement


Collaboration
Period End2021-03-13
Value60.0
Percentage of CollaborationArrangementPercentOfGlobalDevelopmentAndCommercializationCosts150.0

gild:CollaborationArrangementPercentOfGlobalProductRevenues us-gaap:ProductOrService, us-gaap:TypeOfArrangement

gild:CollaborationArrangementPercentOfGlobalProductRevenues

gild:InjectableFormulationProduct, gild:MerckSharpDohmeCorpLicenseAndCollaborationAgreement


Collaboration
Period End2021-03-13
Value65.0
Percentage of CollaborationArrangementPercentOfGlobalProductRevenues100.0

gild:OralFormulationProduct, gild:MerckSharpDohmeCorpLicenseAndCollaborationAgreement


Collaboration
Period End2021-03-13
Value65.0
Percentage of CollaborationArrangementPercentOfGlobalProductRevenues100.0

gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType

gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased

gild:ArcusBiosciencesIncArcus, us-gaap:SubsequentEvent


Equity
Period End2020-07-13
Value0.35
Percentage of EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased100.0

gild:EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:ArcusBiosciencesInc, gild:ArcusStockPurchaseAgreement


Equity
Period End2020-07-13
Value35.0
Percentage of EquitySecuritiesFVNIMaximumPercentageOfOutstandingStockAllowedToBePurchased10000.0

gild:EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments

gild:TangoTherapeuticsInc, gild:AmendedAndRestatedResearchCollaborationAndLicenseAgreementAndStockPurchaseAgreement


Equity
Period End2020-08-17
Value410
Percentage of EquitySecuritiesFVNIOptionOptInExtensionAndMilestonePayments100.0

gild:EquitySecuritiesFVNISharesAcquired us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:EquitySecuritiesFVNISharesAcquired

gild:ArcusBiosciencesInc, gild:ArcusStockPurchaseAgreement


Equity
Period End2021-03-312020-05-29
Value5700000.08200000.0
Percentage of EquitySecuritiesFVNISharesAcquired100.0100.0

gild:FiniteLivedIntangibleAssetsGrossReclassified us-gaap:FiniteLivedIntangibleAssetsByMajorClass

gild:FiniteLivedIntangibleAssetsGrossReclassified

gild:Trodelvy


Finite
Period End2021-04-30
Value1000
Percentage of FiniteLivedIntangibleAssetsGrossReclassified100.0

gild:FiniteLivedIntangibleAssetsGrossReclassified us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

us-gaap:InProcessResearchAndDevelopment


Finite
Period End2021-04-30
Value1000
Percentage of FiniteLivedIntangibleAssetsGrossReclassified100.0

gild:FiniteLivedIntangibleAssetsGrossReclassified us-gaap:StatementScenario, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:SubsequentEventType

srt:ScenarioForecast, us-gaap:InProcessResearchAndDevelopment, us-gaap:SubsequentEvent


Finite
Period End2021-06-30
Value1000
Percentage of FiniteLivedIntangibleAssetsGrossReclassified0.0

gild:InvestmentOwnedBalanceAdditionalPayable us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:InvestmentOwnedBalanceAdditionalPayable

gild:PionyrImmunotherapeuticsInc, gild:PionyrMergerAndOptionAgreements


Investment
Period End2020-07-13
Value6000000.0
Percentage of InvestmentOwnedBalanceAdditionalPayable100.0

gild:IssuanceDiscountPremium us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:IssuanceDiscountPremium

gild:ArcusBiosciencesInc, gild:ArcusCollaborationAgreementAndStockPurchaseAgreements


Issuance
Period End2020-07-13
Value-65.0
Percentage of IssuanceDiscountPremium100.0

gild:ArcusBiosciencesInc, gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreement


Issuance
Period End2020-07-13
Value-65.0
Percentage of IssuanceDiscountPremium100.0

gild:PaymentForAdjustmentsOfBudgetedDevelopmentCosts us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

gild:PaymentForAdjustmentsOfBudgetedDevelopmentCosts

gild:Galapagos, us-gaap:SubsequentEvent, gild:AmendedFilgotinibLicenseAndCollaborationAgreementInDecember2020


Payment
Period End2021-01-31
Value35
Percentage of PaymentForAdjustmentsOfBudgetedDevelopmentCosts100.0

gild:PaymentsForDirectTransactionalExpense us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:PaymentsForDirectTransactionalExpense

gild:ArcusBiosciencesInc, gild:ArcusCollaborationAgreementAndStockPurchaseAgreements


Payments
Period End2020-07-13
Value16
Percentage of PaymentsForDirectTransactionalExpense100.0

gild:ArcusBiosciencesInc, gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreement


Payments
Period End2020-07-13
Value16
Percentage of PaymentsForDirectTransactionalExpense100.0

gild:PaymentsForResearchAndDevelopmentMilestones us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

gild:PaymentsForResearchAndDevelopmentMilestones

gild:PionyrImmunotherapeuticsInc, us-gaap:SubsequentEvent, gild:ResearchAndDevelopmentServiceAgreement


Payments
Period End2021-02-25
Value70
Percentage of PaymentsForResearchAndDevelopmentMilestones100.0

gild:PaymentsToAcquireEquitySecuritiesFVNI us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:PaymentsToAcquireEquitySecuritiesFVNI

gild:ArcusBiosciencesInc, gild:ArcusStockPurchaseAgreement


Payments
Period End2021-03-31
Value220
Percentage of PaymentsToAcquireEquitySecuritiesFVNI100.0

gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods

gild:Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods


Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-31
Value206224188201171155
Percentage of Revenuesrecognizedfromperformanceobligationssatisfiedinpreviousperiods100.0100.0100.0100.0100.0100.0

gild:TotalUpfrontPaymentsMade us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:SubsequentEventType, us-gaap:TypeOfArrangement

gild:TotalUpfrontPaymentsMade

gild:JounceTherapeuticsInc, us-gaap:SubsequentEvent, gild:LicenseRegistrationRightsAndStockPurchaseAgreement


Total
Period End2020-10-31
Value120
Percentage of TotalUpfrontPaymentsMade100.0

gild:TotalUpfrontPaymentsMade us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:ArcusBiosciencesInc, gild:ArcusCollaborationAgreementAndStockPurchaseAgreements


Total
Period End2020-07-13
Value391
Percentage of TotalUpfrontPaymentsMade0.0

gild:ArcusBiosciencesInc, gild:OptionLicenseAndCollaborationAgreementAndCommonStockPurchaseAgreementAndInvestorRightsAgreement


Total
Period End2020-07-13
Value391
Percentage of TotalUpfrontPaymentsMade0.0

gild:JounceTherapeuticsInc, gild:LicenseRegistrationRightsAndStockPurchaseAgreement


Total
Period End2020-10-31
Value120
Percentage of TotalUpfrontPaymentsMade100.0

gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements us-gaap:TypeOfArrangement

gild:UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements

gild:OtherCollaborationArrangements


Upfront
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-30
Value96627.0259740165
Percentage of UpfrontCollaborationExpensesRelatedToOtherCollaborativeArrangements100.0100.0100.0100.0100.0100.0100.0

us-gaap:AdjustmentForAmortization

us-gaap:AdjustmentForAmortization


Adjustment
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value440395348282281281281281288299301301300301319245244245244255241241233237235232244226237216101434750515047465455576259534242
Percentage of AdjustmentForAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationAcquisitionRelatedCosts us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationAcquisitionRelatedCosts

gild:ImmunomedicsInc


Business
Period End2020-12-31
Value615
Percentage of BusinessCombinationAcquisitionRelatedCosts100.0

gild:MYRGmbH


Business
Period End2021-03-31
Value11
Percentage of BusinessCombinationAcquisitionRelatedCosts0.0

us-gaap:BusinessCombinationConsiderationTransferred1 us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationConsiderationTransferred1

gild:ImmunomedicsInc


Business
Period End2020-10-232020-09-24
Value2060021000
Percentage of BusinessCombinationConsiderationTransferred1100.0100.0

gild:MYRGmbH


Business
Period End2021-03-042020-12-10
Value13001200
Percentage of BusinessCombinationConsiderationTransferred10.00.0

us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory

gild:ImmunomedicsInc


Business
Period End2020-10-23
Value881
Percentage of BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory100.0

us-gaap:CommonStockDividendsPerShareDeclared

us-gaap:CommonStockDividendsPerShareDeclared


Common
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-30
Value0.680.680.680.630.630.630.630.570.570.570.570.520.520.520.520.470.470.470.430.430.430.430000
Percentage of CommonStockDividendsPerShareDeclared100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:ConcentrationRiskPercentage1 us-gaap:MajorCustomers, us-gaap:ConcentrationRiskByBenchmark, us-gaap:ConcentrationRiskByType

us-gaap:ConcentrationRiskPercentage1

gild:AmerisourcebergenCorp, us-gaap:RevenueFromContractWithCustomer, us-gaap:CustomerConcentrationRisk


Concentration
Period End2021-06-302021-03-312020-06-302020-03-31
Value21.027.021.022.0
Percentage of ConcentrationRiskPercentage1100.0100.0100.0100.0

gild:AmerisourcebergenCorp, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk


Concentration
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value30.00.210.220.210.20.210.20.20.210.210.2
Percentage of ConcentrationRiskPercentage10.01.01.00.00.00.00.00.00.00.00.0

gild:CardinalHealthInc, us-gaap:RevenueFromContractWithCustomer, us-gaap:CustomerConcentrationRisk


Concentration
Period End2021-06-302021-03-312020-06-302020-03-31
Value23.018.023.022.0
Percentage of ConcentrationRiskPercentage1109.566.7109.5100.0

gild:CardinalHealthInc, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk


Concentration
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value19.00.230.220.210.210.20.20.20.210.190.17
Percentage of ConcentrationRiskPercentage10.01.11.00.00.00.00.00.00.00.00.0

gild:MckessonCorp, us-gaap:RevenueFromContractWithCustomer, us-gaap:CustomerConcentrationRisk


Concentration
Period End2021-06-302021-03-312020-06-302020-03-31
Value17.017.023.021.0
Percentage of ConcentrationRiskPercentage181.063.0109.595.5

gild:MckessonCorp, us-gaap:SalesRevenueNet, us-gaap:CustomerConcentrationRisk


Concentration
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value22.00.230.210.230.20.20.220.210.20.250.23
Percentage of ConcentrationRiskPercentage10.01.11.00.00.00.00.00.00.00.00.0

us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice

us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice


Contract
Period End2021-06-302021-03-312020-06-302020-03-312018-06-30
Value141332433891
Percentage of ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod

us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod


Contract
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1343389.017115514616722297
Percentage of ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod us-gaap:ProductOrService

us-gaap:Royalty


Contract
Period End2021-06-302021-03-312020-06-302020-03-31
Value209226224188
Percentage of ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod0.00.0520.9494.7

us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:VariableRate

us-gaap:DebtInstrumentBasisSpreadOnVariableRate1

gild:A015LIBORSeniorUnsecuredNotesDueSeptember2021, us-gaap:SeniorNotes, us-gaap:LondonInterbankOfferedRateLIBOR


Debt
Period End2021-03-31
Value0.15
Percentage of DebtInstrumentBasisSpreadOnVariableRate1100.0

gild:A052LIBORSeniorUnsecuredNotesDueSeptember2023, us-gaap:SeniorNotes, us-gaap:LondonInterbankOfferedRateLIBOR


Debt
Period End2021-03-31
Value0.52
Percentage of DebtInstrumentBasisSpreadOnVariableRate1346.7

us-gaap:Depreciation

us-gaap:Depreciation


Depreciation
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value79787973686869666060575756567852544948444342454138373140282426252623222020191817171817151517
Percentage of Depreciation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet


Derivative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-15.034-41.0-13.0-21.024-7.040-5.0-6.0-13.01510.0-14.0-1.0-2.025-135.0534-62.0-115.0-151.02821-40.010852738.0081.103-16.318-41.9299.07732-35.544-31.97393-27.1745586-34.344-85.84634-106.9188354
Percentage of DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DividendsCommonStockCash

us-gaap:DividendsCommonStockCash


Dividends
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value8658668668678088078108147417467477526876856856856226256315876206316390.0
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents


Effect
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value20-23.0413726-61.042-55.0-9.020-39.0
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiUnrealizedLoss

us-gaap:EquitySecuritiesFvNiUnrealizedLoss


Equity
Period End2020-12-312020-09-302018-09-302018-06-30
Value654964-168.064
Percentage of EquitySecuritiesFvNiUnrealizedLoss100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiUnrealizedLoss us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:TypeOfArrangement

gild:Galapagos, gild:GalapagosSubscriptionAgreement


Equity
Period End2020-12-312020-09-30
Value628983
Percentage of EquitySecuritiesFvNiUnrealizedLoss96.0102.0

gild:Galapagos, gild:OptionLicenseAndCollaborationAgreementAndSubscriptionAgreement


Equity
Period End2020-09-30
Value923
Percentage of EquitySecuritiesFvNiUnrealizedLoss95.7

us-gaap:GoodwillAcquiredDuringPeriod

us-gaap:GoodwillAcquiredDuringPeriod


Goodwill
Period End2021-03-31
Value226
Percentage of GoodwillAcquiredDuringPeriod100.0

us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment

us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment


Income
Period End2020-09-302020-06-30
Value5114500
Percentage of IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment100.0100.0

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-219.0-316.0-350.0-67.0-234.0-127.0165381-25.0-249.092287-1220.0-618.05545-120.096-24.0-19.0384440205-254.0-51.0425149397-161.99856240117-129.40230127.20126-2.942-99.15125332031-50.23429-15.128-149.719
Percentage of IncreaseDecreaseInAccruedIncomeTaxesPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilities


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value25-738.0582145463-550.0335-236.0-71.0-417.0-190.0-643.0155164206-675.0328-677.0-632.0181681195155725151530756379710166451676173-11.7681201661101947.951376122661218
Percentage of IncreaseDecreaseInAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi

us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value174-351.0-616.0-964.0201-283.09295857197-34.0168
Percentage of IncreaseDecreaseInEquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value-6.08.023654-30.0-46.082191-9.043-154.0-127.0-93.0-529.0-47.0-166.032-177.0-265.0450209126-77.040179-52.0-57.969-92.77935216959-42.602-33.5031871977-42.8477527-2.489-34.78723646.1176.006-6.305
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements


Incremental
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
Value5.06.06.00.08.00.00.07.07.0-1.01110.0130.01310.012-2.0131416-1.0212326-0.7693131350.4438383617161414-0.204131415-0.514141620
Percentage of IncrementalCommonSharesAttributableToShareBasedPaymentArrangements100.0100.0100.00.0100.00.00.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LossContingencyDamagesSoughtValue us-gaap:LitigationCase, us-gaap:LitigationStatus

us-gaap:LossContingencyDamagesSoughtValue

gild:ViiVHealthcareCompany, us-gaap:PendingLitigation


Loss
Period End2021-06-302021-03-31
Value130601440
Percentage of LossContingencyDamagesSoughtValue100.0100.0

us-gaap:MinorityInterestPeriodIncreaseDecrease

us-gaap:MinorityInterestPeriodIncreaseDecrease


Minority
Period End2020-12-312020-09-302020-06-302018-12-312018-09-302017-12-312017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-09-30
Value0.0-82.010.01.082-382.01.0-58.03.0-7.04147191
Percentage of MinorityInterestPeriodIncreaseDecrease0.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:MinorityInterestPeriodIncreaseDecrease us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest


Minority
Period End2020-12-312020-09-302020-06-302018-12-312018-09-302017-12-312017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-09-30
Value0.0-82.010.01.082-379.01.0-58.03.0-7.04147191
Percentage of MinorityInterestPeriodIncreaseDecrease0.0100.0100.0100.0100.099.2100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax


Other
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-31
Value-1.0-2.0-9.074-23.04.01930
Percentage of OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-30
Value-1.0-2.0-24.0-13.072-34.00.04.01930183134-36.0-94.0184-67.0187-151.023152-24.0-31.00.0-3.06.0-0.558-0.8821.492-0.0520.4634.251-2.0771.7680.1253.9050.08430-11.992-27.442-0.722
Percentage of OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent


Other
Period End2021-06-302021-03-312020-06-302020-03-31
Value-13.068-36.057
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax100.0100.0100.0100.0

us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges


Other
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
Value-78.0-46.0-36.057-27.070292861-6.057-61.0-26.0-76.0-115.0-87.0254173223311.265-56.282-82.453
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax0.00.0100.0100.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
Value-1.0-2.01.0-9.074-23.01.04.049301831-6.0-36.0-93.0185-58.0184-152.0-0.995-0.8311.6790.1470.7854.316
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax7.7-2.90.00.0-205.6-40.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value-19.076-67.0-32.042-5.0-1.0478679582633-90.0-115.0105-144.021
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax146.2111.80.00.0-116.7-8.80.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
Value-5.010.010.0234.0-39.025-27.08.021-21.01.0-18.07.04.0-4.029-76.0216-5.938-10.0311.1865.783-49.5952.381
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax38.514.70.00.0-11.1-68.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value-13.068-78.0-46.0-36.057-27.0701.02861